2018 Annual Meeting | P2 - Poster Session II

Date Monday 04/23/18

Time 11:30 AM - 07:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology, Pain, Research Methodology, Education, and History

CME Available 0.00 credit

Event Timeline
11:30 AM - 07:00 PM	Abstract	001 - Common difficulties medical students have with the neurological physical exam are identified by direct observation. Juliana J. Coleman, MD
11:30 AM - 07:00 PM	Abstract	002 - Evaluation of a Single Year Competency-Based Clerkship Alternative to Effectively Navigate a Fourth-Year to Third Year Curricular Transition Jeff Kraakevik, MD, FAAN
11:30 AM - 07:00 PM	Abstract	003 - Developing a Student-Centric/Student Responsive Four Week Neurology Clerkship Raghav Govindarajan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	004 - Published Headache OSCEs Have Excellent Inter-rater Reliability Maryam Shakir, MPH
11:30 AM - 07:00 PM	Abstract	005 - Why aren't you giving feedback? Doris Kung, DO, FAAN
11:30 AM - 07:00 PM	Abstract	006 - Movement Disorders Video Curriculum for Neurology Clerkships and Residency Programs Sagari R. Bette, MD
11:30 AM - 07:00 PM	Abstract	007 - Assessment Of The Difficult Components Of Neurological Exam Performance In Medical Students Yi Li, MD
11:30 AM - 07:00 PM	Abstract	008 - Animated Neurological Exam Videos in PBL Cases J. Douglas Miles, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	009 - Student Neurology Clerkship Improvement Project ("SNIP") Victoria A. Cannon, MD
11:30 AM - 07:00 PM	Abstract	010 - Incorporating Formal Nutrition Education into a Medical School Curriculum: A Student-Initiated Lecture Series Vanessa Baute Penry, MD
11:30 AM - 07:00 PM	Abstract	011 - Expert Patient Tutors: The Eradication of Neurophobia Gina L. Hadley, MD
11:30 AM - 07:00 PM	Abstract	012 - Common Data Elements (CDEs) for Biomechanical Devices used in Blunt Head Impact and Blast Exposure Dynamics: The National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) and Department of Defense (DOD) Version 1.0 Recommendations Kristen R. Joseph, MA
11:30 AM - 07:00 PM	Abstract	013 - Development of diagnostic criteria to facilitate research in mitochondrial disorders: a proposal from the North American Mitochondrial Disease Consortium. Valentina Emmanuele, MD, PhD
11:30 AM - 07:00 PM	Abstract	014 - Streamlining Clinical Research in Sports-Related Concussion: The National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH), and Department of Defense (DOD) Sport-Related Concussion Common Data Elements (CDEs) Kristen R. Joseph, MA
11:30 AM - 07:00 PM	Abstract	015 - Registration status of clinical trials published in core neurology journals: a cross-sectional study Jose G. Merino, MD, MPhil, FAHA, FAAN
11:30 AM - 07:00 PM	Abstract	016 - A Common Language for Clinical Research Studies: The National Institute of Neurological Disorders and Stroke (NINDS) and Centers for Disease Control and Prevention (CDC) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Common Data Elements (CDEs) Robin S. Feldman
11:30 AM - 07:00 PM	Abstract	017 - Headache interest in US academic neurology leadership: a cross-sectional study Matthew S. Robbins, MD, FAAN
11:30 AM - 07:00 PM	Abstract	018 - Neurology Residency Websites: A Critical Evaluation. Adeel A. Memon, MD
11:30 AM - 07:00 PM	Abstract	019 - The Rutgers-NJMS Experience: Why Are Our Medical Students Increasingly Applying to Adult Neurology? Jessy Walia, MBBS
11:30 AM - 07:00 PM	Abstract	020 - Changing the Image of Neurology Yolanda Reyes-Iglesias, MD, FAAN
11:30 AM - 07:00 PM	Abstract	021 - The Importance of Neurology as a Required Third-Year Clerkship: a Medical Student Survey
11:30 AM - 07:00 PM	Abstract	022 - The Impact of Early Medical School Exposure to Clinical Neurology on Career Interest in Neurology Yasmin Aghajan, MD
11:30 AM - 07:00 PM	Abstract	023 - NA
11:30 AM - 07:00 PM	Abstract	024 - NA
11:30 AM - 07:00 PM	Abstract	025 - NA
11:30 AM - 07:00 PM	Abstract	026 - NA
11:30 AM - 07:00 PM	Abstract	027 - Machine-learning in neurodegeneration: evaluation, optimisation and validation of MRI-based diagnostic methods Peter Bede, MD, PhD
11:30 AM - 07:00 PM	Abstract	028 - Skeletal Muscle Interstitial Amyloid in Anoctaminopathy-5: Does it Matter? Charenya Anandan, MD
11:30 AM - 07:00 PM	Abstract	029 - Egr2-dependent microRNA-138 is Dispensable for Peripheral Nerve Myelination
11:30 AM - 07:00 PM	Abstract	030 - The Long Exercise Test in Primary Periodic Paralysis: a Bayesian Analysis Daniel B. Simmons, MD
11:30 AM - 07:00 PM	Abstract	031 - Congenital Myasthenic Syndromes (CMS) Due to Impaired Principal Coupling Pathway in the ? Subunit of Muscle Acetylcholine Receptor (AChR) Xin Ming Shen, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	032 - Integrated MRI and [11C]-PBR28 PET Imaging to Characterize In vivo Glial Activation in Amyotrophic and Primary Lateral Sclerosis: Cross Sectional and Longitudinal Study Mohamad J. Alshikho, MD
11:30 AM - 07:00 PM	Abstract	033 - Undiagnosed Congenital Myasthenic Syndromes in Adult Neuromuscular Practice: a Long Road to Diagnosis and Treatment. Justin Kao, MBChB
11:30 AM - 07:00 PM	Abstract	034 - ALS progression over short time intervals: early insights from the ongoing ALS-at-home study Seward B. Rutkove, MD, FAAN
11:30 AM - 07:00 PM	Abstract	035 - Efficacy of Dichlorphenamide in Primary Periodic Paralysis: Pooled-Data Analysis of Two Phase 3 Clinical Trials Perry Shieh, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	036 - Decreased EEG Spectral Power and Increased Cortico-Cortical Connectivity Correlate with Structural MRI Changes in Amyotrophic Lateral Sclerosis Stefan Dukic
11:30 AM - 07:00 PM	Abstract	037 - Effects of Probiotics on Constipation, Neurological Symptoms, and Quality of Life Associated with Parkinson's Disease Duarte G. Machado, MD, FAAN
11:30 AM - 07:00 PM	Abstract	038 - Exploratory risk analysis for motor complications and non-motor symptoms: observations in a registry of a tertiary Parkinson's disease center in Brasilia, Brazil Talyta Grippe, MD
11:30 AM - 07:00 PM	Abstract	039 - A Phase 2 study of Isradipine as a disease modifying agent in patients with early Parkinson's disease (STEADY-PD III): Baseline characteristics and study update Tanya Simuni, MD, FAAN
11:30 AM - 07:00 PM	Abstract	040 - Optimizing Delivery of Carbidopa/Levodopa via the Accordion Pill™: Comparative PK and Safety From 2 Randomized Crossover Studies in Healthy Volunteers
11:30 AM - 07:00 PM	Abstract	041 - Objective Evaluation of Levodopa Response on Gait and Balance
11:30 AM - 07:00 PM	Abstract	042 - Effect of PD medication on disease progression as measured by rate of change in MDS_UPDRS in PPMI study Zhen Xiao, PhD
11:30 AM - 07:00 PM	Abstract	043 - Pharmacokinetics of ADS-5102 (amantadine) Extended Release Capsules Administered Once-Daily at Bedtime for the Treatment of Dyskinesia Robert A. Hauser, MD, MBA, FAAN
11:30 AM - 07:00 PM	Abstract	044 - The iNDiGO study: A multicenter, randomized, double-blind, placebo-controlled clinical study investigating the efficacy, tolerability, and safety of two dosing regimens of continuous subcutaneous ND0612 infusion given as adjunct treatment to oral levodopa in fluctuating PD Karl D. Kieburtz, MD
11:30 AM - 07:00 PM	Abstract	045 - A Phase 3 Study of Tozadenant (TOZ-PD) as a Maintenance Therapy for Patients With Parkinson's Disease Experiencing Motor Fluctuations: Characterization of Study Population Karl D. Kieburtz, MD
11:30 AM - 07:00 PM	Abstract	046 - Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson's Disease James T. Boyd, MD
11:30 AM - 07:00 PM	Abstract	047 - Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease Patients Receiving ≥ 2000 mg Daily Dose of Levodopa Cindy Zadikoff, MD
11:30 AM - 07:00 PM	Abstract	048 - Rationale and Design of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson's Disease - INSIGHTS Study Kallol R. Chaudhuri, MD, FRCP
11:30 AM - 07:00 PM	Abstract	049 - Dry facts are not always inviting: an analysis of Korean videos about Parkinson's disease on YouTube Beomseok Jeon, MD
11:30 AM - 07:00 PM	Abstract	050 - Clinical factors associated with clinician certainty in diagnosis of idiopathic Parkinson's disease Kishan Ughreja, BA
11:30 AM - 07:00 PM	Abstract	051 - Item Response Theory Analysis of the Unified Dyskinesia Rating Scale Items Christopher Goetz, MD, FAAN
11:30 AM - 07:00 PM	Abstract	052 - A Clinically Important Difference (CID) for the Unified Dyskinesia Rating Scale (UDysRS) Total Score Change in Parkinson's Disease (PD) Patients with Dyskinesia Rajesh Pahwa, MD, FAAN
11:30 AM - 07:00 PM	Abstract	053 - Smoking and Coffee Consumption Preceding Clinically-diagnosed Synucleinopathies: A Case-control Study in Olmsted County MN (1991-2005).
11:30 AM - 07:00 PM	Abstract	054 - Predictors of Disability in Parkinson Disease: Motor vs. Cognitive Impairment Using MMSE vs. MoCA Allison Snyder, MD
11:30 AM - 07:00 PM	Abstract	055 - Communication Regarding Off Time with People with Parkinsons and their Caregivers: Qualitative Analysis of Physician Interviews Tara R. Rastin, MD
11:30 AM - 07:00 PM	Abstract	056 - Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross-sectional Analysis of the MJFF Fox Insight (FI) Platform Lakshmi Arbatti, NLP
11:30 AM - 07:00 PM	Abstract	057 - Stumbling, Near-falls, Freezing or Postural Instability: What Predicts Falling Best in Parkinson Disease? Zahra N. Rezvani, MD
11:30 AM - 07:00 PM	Abstract	058 - Diagnostic Impact of Movement Disorders Subspecialty Consultations at a VA Hospital Brandon R. Barton, MD, FAAN
11:30 AM - 07:00 PM	Abstract	059 - Levodopa-induced dyskinesias in Parkinson disease: a population based-cohort study in Olmsted County, MN (1991-2010) Pierpaolo Turcano, MD
11:30 AM - 07:00 PM	Abstract	060 - A Real-World Inquiry of the So-Called Parkinsonian Personality -- Comparing No-Show Rates of the Neurology Outpatients with and without Parkinson's disease (PD) Jeremiah F. Bell, MD
11:30 AM - 07:00 PM	Abstract	061 - Parkinson's Diagnostic Accuracy- What diagnoses cause the most diagnostic-switches by Movement Disorder Specialists?
11:30 AM - 07:00 PM	Abstract	062 - Barriers to Vaccination in Homebound and Non-Homebound People with Parkinson's Disease Jori Fleisher, MD, MSCE, FAAN
11:30 AM - 07:00 PM	Abstract	063 - Traumatic brain injury and erectile dysfunction preceding clinically diagnosed alpha-synucleinopathies: a case - control study in Olmsted County, MN (1991-2010). Shemonti Hasan, MD
11:30 AM - 07:00 PM	Abstract	064 - Objective Markers of Turning in Idiopathic Parkinson's Disease Lakshmi Pillai
11:30 AM - 07:00 PM	Abstract	066 - Prevalence and patterns of rest, postural and action tremor in drug-naive Parkinson's disease Deepak K. Gupta, MBBS
11:30 AM - 07:00 PM	Abstract	067 - Experiences, impact, and communication of "off" periods in Parkinson's disease: qualitative experiences of patients and carepartners Tara R. Rastin, MD
11:30 AM - 07:00 PM	Abstract	068 - Characteristics of Patients with Parkinson Disease in Pakistan: Prospective Multicenter Cross-sectional Study
11:30 AM - 07:00 PM	Abstract	069 - Predictors of health-related quality of life in Parkinson's disease Greg D. Kuhlman, MD
11:30 AM - 07:00 PM	Abstract	070 - Prenatal Exposure to Chlorpyrifos and Parkinson's risk: a prospective adolescent cohort evaluation Sarah A. O'Shea, MD
11:30 AM - 07:00 PM	Abstract	071 - Primary Care Knowledge and Referral Practices Based on Early Symptoms of Parkinson's Disease Stephanie L. Bissonnette, DO
11:30 AM - 07:00 PM	Abstract	072 - Characterizing Types of Falls in Parkinson's Disease Abraham N. Lieberman, MD, FAAN
11:30 AM - 07:00 PM	Abstract	073 - Healthcare Disparities in African-American Patients with Parkinson's Disease : A Comprehensive Literature Review and Call to Action Shivani Naik, MD
11:30 AM - 07:00 PM	Abstract	074 - Deeply Phenotyped Control Cohort for Studies of Parkinson's Disease Rana Hanna AL-Shaikh, MD
11:30 AM - 07:00 PM	Abstract	075 - The Prevalence of Tandem Gait Abnormality in Parkinson's Disease Jason H. Margolesky, MD, FAAN
11:30 AM - 07:00 PM	Abstract	076 - Instructed Arm Swing Improves Walking Performance and Decreases Fall Risk in Individuals with Parkinsonism Evan Fitzgerald
11:30 AM - 07:00 PM	Abstract	077 - Development of a Parkinson's Disease-Specific Admission Order Set Danielle Larson, MD
11:30 AM - 07:00 PM	Abstract	078 - Sex Disparities in Health and Health Care Utilization after Parkinson Diagnosis: Rethinking PD Associated Disability Michelle Fullard, MD
11:30 AM - 07:00 PM	Abstract	079 - Characterization of variants in genes associated with Parkinson´s disease and parkinsonism in the African American population using exome sequencing Angela B. Deutschlander, MD
11:30 AM - 07:00 PM	Abstract	080 - Presentation of Parkinson's disease in patients originating of different geographical altitudes Kelly J. Meza Capcha, Sr.
11:30 AM - 07:00 PM	Abstract	081 - Differences in Quality of Life Between Men and Women with Parkinson's Disease Medha Gudavalli
11:30 AM - 07:00 PM	Abstract	082 - Predictors of Clinically Meaningful Change in PDQ-39 in Parkinson's Disease Adam J. Margolius, MD
11:30 AM - 07:00 PM	Abstract	083 - Use of a modified STROOP test to help with diagnosis in early idiopathic Parkinson's disease Rebekah G. Langston
11:30 AM - 07:00 PM	Abstract	084 - NA
11:30 AM - 07:00 PM	Abstract	085 - A splice-site mutation in USMG5 causes Leigh Syndrome due to lack of ATP synthesis Emanuele Barca, MD, PhD
11:30 AM - 07:00 PM	Abstract	086 - Long-term Neurodevelopmental Outcomes in Preterm Infants with Posthemorrhagic Hydrocephalus Treated with Temporizing Devices Lydia J. Bernhardt
11:30 AM - 07:00 PM	Abstract	087 - Clinical profile and outcome of children with Lennox Gastaut Syndrome: Retrospective single centre cohort
11:30 AM - 07:00 PM	Abstract	088 - Iron and ferritin levels in patients with ADHD Shreya Agarwal
11:30 AM - 07:00 PM	Abstract	089 - Unusual Presentation of Wilson Disease in a Pediatric Patient: Case Report Michael DiSano, MD
11:30 AM - 07:00 PM	Abstract	090 - Striatal Changes on MRI in Young Children with NMDAR: A Single Center Experience Michael B. Nelson, MD, MPH
11:30 AM - 07:00 PM	Abstract	091 - Gluten Neuropathy: Prevalence of Pain and the Role of Gluten-Free Diet. Panagiotis Zis, MBBS, PhD
11:30 AM - 07:00 PM	Abstract	093 - ALS Patient Perspectives on Physician Assisted Death After Recent Passage of End of Life Options Act Nicole Heinl
11:30 AM - 07:00 PM	Abstract	094 - Prognostic Factors and Effectiveness of Percutaneous Balloon Compression in the Treatment of Trigeminal Neuralgia: An Experience of 222 patients
11:30 AM - 07:00 PM	Abstract	095 - Evaluation of Pain Reproduction and other Predictive Factors of Selective Lumbar Nerve Block Efficacy for the Diagnosis and Palliative Treatment of Chronic Low Back Pain: A Retrospective Cohort Study Yi Tong
11:30 AM - 07:00 PM	Abstract	096 - Widespread Myofascial Dysfunction and Regional Sensitization in Women with Endometriosis-associated Chronic Pelvic Pain Barbara P. Karp, MD, FAAN
11:30 AM - 07:00 PM	Abstract	098 - Botulinum Toxin Treatment of Chronic Pelvic Pain in Women with Endometriosis Barbara P. Karp, MD, FAAN
11:30 AM - 07:00 PM	Abstract	099 - Evaluation of Clinical Symptom and Signs Related to Histological and Functional Properties of Small Fiber Neuropathy in Diabetic Neuropathic Pain Patients Isin Unal-Cevik, MD, PhD
11:30 AM - 07:00 PM	Abstract	100 - Polarity-specific Modulation of Central Pain Processing by Transcranial Direct Current Stimulation Steffen Naegel, MD
11:30 AM - 07:00 PM	Abstract	102 - Biotin-deficiency in patients with fibromyalgia syndrome combined with small fiber pathology. Walter Maier-Janson, MD
11:30 AM - 07:00 PM	Abstract	103 - 'Triggers' for a Palliative Care Service for Patients with Spinocerebellar Ataxia Type 1. Patama Gomutbutra, MD
11:30 AM - 07:00 PM	Abstract	104 - Evaluation of Berberin- a Nrf2 Activator, on Paclitaxel-Induced Neuropathic Pain Model in Rat Amitava Chakrabarti, MD, MBBS
11:30 AM - 07:00 PM	Abstract	105 - The Effectiveness of Spinal Cord Stimulation (SCS) In Reduction of Oral Opioid Use Derek Yuan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	106 - Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation for the Treatment of Fibromyalgia: An open label clinical trial
11:30 AM - 07:00 PM	Abstract	107 - Successful Treatment of Refractory Trigeminal Neuralgia with Sphenopalatine Ganglion Block Mohamed Falah, MD, FAAN
11:30 AM - 07:00 PM	Abstract	108 - Inflamed Brain: A Neuro-Palliative Approach Justin Voorhees, MD
11:30 AM - 07:00 PM	Abstract	109 - Autoimmune polyneuropathy with severe dysautonomia after ipilimumab treatment for melanoma Kyle Kern, MD, MS
11:30 AM - 07:00 PM	Abstract	110 - A Case of Paraneoplastic Dysautonomia and Small Fiber Neuropathy Jacob Didion, MD
11:30 AM - 07:00 PM	Abstract	111 - Diagnostic Utility of Sweat Gland Nerve Fiber Density in Small Fiber Neuropathy Peter Novak, MD
11:30 AM - 07:00 PM	Abstract	112 - Dysautonomia in Charcot-Marie-Tooth Disease and Correlations with Patient-Reported Disability Sindhu Ramchandren, MD
11:30 AM - 07:00 PM	Abstract	113 - Small Fiber Neuropathy and Multiple Endocrinopathies with COX6A1 Gene Deletion Glen A. Cook, Jr., MD, FAAN
11:30 AM - 07:00 PM	Abstract	114 - Characterizing the spectrum of autonomic impairment in neurologic disorders with calcium channel antibodies Julie A. Khoury, MD
11:30 AM - 07:00 PM	Abstract	115 - Autonomic description in patients with very early TTR amyloidosis (Familial Amyloid Polyneuropathy). Maria Alejandra Gonzalez Duarte, MD, FAAN
11:30 AM - 07:00 PM	Abstract	116 - The effect of vagal dysfunction on cytokine networks in HIV Elizabeth Pedowitz, MD
11:30 AM - 07:00 PM	Abstract	117 - Healthcare Related Costs of Autonomic Disorders in MHS Beneficiaries
11:30 AM - 07:00 PM	Abstract	118 - Progressive Multiple Sclerosis Patients Have a Higher Burden of Autonomic Dysfunction Compared to Relapsing Remitting Phenotype Ivan Adamec
11:30 AM - 07:00 PM	Abstract	119 - Psychosis in Multiple System Atrophy Jose-Alberto Palma, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	120 - Long-term Fingolimod therapy increases sympathetic cardiovascular modulation Ruihao Wang, MD
11:30 AM - 07:00 PM	Abstract	121 - Cognitive impairment correlates with autonomic dysfunction in patients with a history of traumatic brain injury Max J. Hilz, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	122 - Seasonal Hypothermia, Hypersomnolence, Encephalopathy, and Hypoventilation Following Hypothalamus Injury - A Case of Human Hibernation? Leighton Mohl, MD
11:30 AM - 07:00 PM	Abstract	123 - Three Shapiro Syndrome cases : diagnostic challenge of clinical spectrum of the spontaneous paroxysmal hypothermia syndrome
11:30 AM - 07:00 PM	Abstract	124 - Autonomic Dysfunction in Patients with Down Syndrome and Alzheimer Disease Eric Huttler
11:30 AM - 07:00 PM	Abstract	125 - Understanding the Symptoms of Neurogenic Orthostatic Hypotension: Results From a Survey of Patients and Caregivers
11:30 AM - 07:00 PM	Abstract	126 - Addressing Orthostatic Hypotension in Parkinson Disease Patients in a Neurology Resident Continuity Clinic Elisabeth Golden, MD
11:30 AM - 07:00 PM	Abstract	127 - Neurogenic Orthostatic Hypotension Burden of Illness Patient and Caregiver Survey: Impact of Symptoms Daniel O. Claassen, MD, FAAN
11:30 AM - 07:00 PM	Abstract	128 - Patient and Caregiver Experiences With the Diagnosis of Neurogenic Orthostatic Hypotension Lawrence Hewitt
11:30 AM - 07:00 PM	Abstract	129 - Persistence of Droxidopa Treatment in Patients With Neurogenic Orthostatic Hypotension
11:30 AM - 07:00 PM	Abstract	130 - Management and Treatment of Neurogenic Orthostatic Hypotension: Results From a Survey of Patients and Caregivers Lawrence Hewitt
11:30 AM - 07:00 PM	Abstract	131 - Short-Term Outcome in Children and Adolescents with Orthostatic Intolerance and Postural Tachycardia Syndrome Imad T. Jarjour, MD, FAAN
11:30 AM - 07:00 PM	Abstract	132 - Joint Hypermobility is Related to Pathological Finding on Tilt Table Testing Ivan Adamec
11:30 AM - 07:00 PM	Abstract	133 - Running-Induced Vertigo in an Adolescent: A Treatable Orthostatic Vestibular Migraine Variant Imad T. Jarjour, MD, FAAN
11:30 AM - 07:00 PM	Abstract	134 - Elevated Paraneoplastic Markers: An Uncommon Finding in Orthostatic Intolerance and Postural Orthostatic Tachycardia Charlene R. Hoffman-Snyder, DNP
11:30 AM - 07:00 PM	Abstract	135 - Postural Orthostatic Tachycardia: The Stanford experience Safwan S. Jaradeh, MD, FAAN
11:30 AM - 07:00 PM	Abstract	136 - Isolated Sixth Cranial Nerve Palsy in Pregnancy Noelia García Lax
11:30 AM - 07:00 PM	Abstract	137 - A case of optic neuropathy due to cat scratch disease (CSD) and syphilis co-infection with characteristic MRI findings Mingyang Meah Gao, MD
11:30 AM - 07:00 PM	Abstract	138 - Wernicke's Encephalopathy After Hyperemesis Gravidarum Pria Anand, MD
11:30 AM - 07:00 PM	Abstract	139 - A Case of Severe Wernicke Encephalopathy with Bilateral Sensorineural Hearing Loss Michael Hansen, MD
11:30 AM - 07:00 PM	Abstract	140 - Objective Evidence of Hyper-rapid Olfactory Adaptation in Cranial Nerve I Dysfunction Khurram Janjua, MD
11:30 AM - 07:00 PM	Abstract	141 - Hypereosinophilia and Neuro-ophthalmological manifestations in Lymphoma Ehtesham Khalid, MBBS
11:30 AM - 07:00 PM	Abstract	142 - Intraorbital Perineural Cyst of the Oculomotor Nerve Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN
11:30 AM - 07:00 PM	Abstract	143 - Horner's Syndrome as the Presenting Symptom in Giant Cell Arteritis
11:30 AM - 07:00 PM	Abstract	144 - Diplopia as the Presenting Symptom of Systemic T Cell Prolymphocytic Leukemia with Infiltration of the Superior Rectus Muscle. Humaira Khan, MD
11:30 AM - 07:00 PM	Abstract	145 - Unilateral proptosis, scleral injection and superior gaze diplopia secondary to spontaneous ophthalmic artery to superior ophthalmic vein fistula - Case report and review of literature Subin Mathew, MD, FAAN
11:30 AM - 07:00 PM	Abstract	146 - Development of Optic Neuritis after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, 1990-2017. Janaki Patel, MD
11:30 AM - 07:00 PM	Abstract	147 - Chronic Relapsing Inflammatory Optic Neuropathy Chaitanya Amrutkar, MD
11:30 AM - 07:00 PM	Abstract	148 - Intravenous immunoglobulin treatment in the management of corticosteroid unresponsive optic neuritis: A retrospective case series of 15 cases Yu Zhao, MD
11:30 AM - 07:00 PM	Abstract	149 - Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic Neuritis Soren Jonzzon
11:30 AM - 07:00 PM	Abstract	150 - Audiological Profile of Multiple Sclerosis Patients in Jordan: A Case-Control Study. Mohammad Alkhoujah, MD
11:30 AM - 07:00 PM	Abstract	152 - Venous Sinus Stenting Improves Visual Fields and Cerebrospinal Fluid Opening Pressures in Patients with Idiopathic Intracranial Hypertension Evan R. Schloss, MD
11:30 AM - 07:00 PM	Abstract	153 - Long-term Symptom Reduction of MdDS Rocking Vertigo with Theta Burst rTMS Benjamin Chipper Doudican
11:30 AM - 07:00 PM	Abstract	154 - 'Sandbagging' a Vision Test for Concussion-based Sideline Assessment: An Eye Movement Investigation Objectively Reveals the 'Gamers' Strategies Janet C. Rucker, MD
11:30 AM - 07:00 PM	Abstract	155 - Field testing the ICHD 3 beta diagnostic criteria of vestibular migraine Mark Obermann, MD, FAAN
11:30 AM - 07:00 PM	Abstract	156 - Psychological Measures of Individuals with Mal de Debarquement Syndrome
11:30 AM - 07:00 PM	Abstract	157 - Vestibular Perceptual Threshold and Motion Sensitivity in Vestibular Migraine and Persistent Postural-Perceptual Dizziness
11:30 AM - 07:00 PM	Abstract	158 - Erlotinib-Induced Dandy's Syndrome: Case Report Kristen K. Steenerson, MD, FAAN
11:30 AM - 07:00 PM	Abstract	159 - Short-Term Memory Loss in Vestibular Patients can Arise Independently of Psychiatric Impairment, Fatigue and Sleeplessness S.S. Surenthiran, MBBS
11:30 AM - 07:00 PM	Abstract	160 - Optimal Inter-Eye Difference Thresholds in Retinal Nerve Fiber Layer and Ganglion Cell Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis: An International Collaborative Study Rachel Nolan
11:30 AM - 07:00 PM	Abstract	161 - Retinal Ganglion Cell Layer and Disease Activity in Clinically Isolated Syndrome
11:30 AM - 07:00 PM	Abstract	162 - Agonist of Growth Hormone Releasing Hormone (GHRH) Protects Retinal Ganglion Cells in a Model of Traumatic Optic Neuropathy Christian Kim
11:30 AM - 07:00 PM	Abstract	163 - Evaluation of neuroprotective properties of dimethylfumarate by optical coherence tomography in non-inflammatory models of retinal neurodegeneration
11:30 AM - 07:00 PM	Abstract	164 - Mkk4 and Mkk7 are Important for Both Retinal Development and Axonal Injury-Induced Retinal Ganglion Cell Death Stephanie Syc-Mazurek, MD, PhD
11:30 AM - 07:00 PM	Abstract	165 - Correlation of Visual Field Loss with MRI Findings in Patients with Pituitary Tumours Christian J. Lueck, MD, FAAN
11:30 AM - 07:00 PM	Abstract	166 - Impact of cataract surgery on cognitive functions in elderly patients presenting to a tertiary care center in Islamabad. Faleha Zafar, MBBS
11:30 AM - 07:00 PM	Abstract	167 - Saccadic Intrusions Are Rare In Multiple Sclerosis
11:30 AM - 07:00 PM	Abstract	168 - Correlative Enhancement: Evaluation of a new postprocessing algorithm for diagnosis of optic neuritis. Leanne Stunkel, MD
11:30 AM - 07:00 PM	Abstract	169 - The New MULES: A Sideline-Friendly Test of Rapid Picture Naming for Concussion Omar Akhand, MD
11:30 AM - 07:00 PM	Abstract	170 - NA
11:30 AM - 07:00 PM	Abstract	171 - NA
11:30 AM - 07:00 PM	Abstract	172 - NA
11:30 AM - 07:00 PM	Abstract	173 - Homozygosity for the A431E mutation in PSEN1 presenting with a relatively aggressive phenotype John Parker, MD
11:30 AM - 07:00 PM	Abstract	174 - Huntington's disease across four generations in a mexican family: Westphal variant with female predominance Jazmin G. Sotelo-Hernandez, MD
11:30 AM - 07:00 PM	Abstract	175 - Fahr's disease due to a novel SLC20A2 gene mutation in a Canadian patient: Early Neurocognitive, Structural and Metabolic changes Leila Sellami, MD
11:30 AM - 07:00 PM	Abstract	176 - Two Distinct Clinical Phenotypes in a Family with ALSP Caused by a Novel CSF-1R Mutation. Ryan G. Taylor, MD
11:30 AM - 07:00 PM	Abstract	177 - A Case of AARS2 Leucoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) Michael Doyle, MRCPI
11:30 AM - 07:00 PM	Abstract	178 - Correlation Between Exercise and Motor Skills with Elderly Patients Cognition Cassio Henrique Taqu Martins
11:30 AM - 07:00 PM	Abstract	179 - Dietary Approaches to Stop Hypertension (DASH) Diet Associated with Lower Rates of Depression Laurel J. Cherian, MD, FAAN
11:30 AM - 07:00 PM	Abstract	180 - An Exploratory Analysis of Lifetime Surgical History and Cognition James R. Bateman III, MD, FAAN
11:30 AM - 07:00 PM	Abstract	181 - Neurostimulation for Functional Weakness: A Longitudinal Evaluation of Cortical Neurophysiology Matthew J. Burke, MD, FRCPC
11:30 AM - 07:00 PM	Abstract	182 - 'Just Google It' – The Effect of Media Events on Patterns of Public Interest in the 'Vaccines Cause Autism' Fallacy from 2004-2017 Shehryar Sheikh
11:30 AM - 07:00 PM	Abstract	183 - Characterization of Regulatory T Lymphocytes in the progression of Alzheimer's Disease Alirexa Faridar, MD
11:30 AM - 07:00 PM	Abstract	184 - Age-Dependent White Matter Inflammation and Cognitive Impairment in the TgAPP21 Rat Model of Alzheimer Disease Alexander Levit
11:30 AM - 07:00 PM	Abstract	185 - Case Control Study of RNA Editing in Blood Reveals Decreased Global Levels of A-to-I Editing in Alzheimer's Disease Olivia Gardner, MD, PhD
11:30 AM - 07:00 PM	Abstract	186 - Genetic Basis of Motoric Cognitive Risk Syndrome in Health and Retirement Study Sanish Sathyan, PhD
11:30 AM - 07:00 PM	Abstract	187 - Familial Adult-onset Neuronal Intranuclear Inclusion Disease Monique M. Montenegro, MD
11:30 AM - 07:00 PM	Abstract	188 - Amyloid-beta Induction of PIAS1 Ser-503 Phosphorylation and Elk-1 SUMOylation Mediate Endogenous Neuroprotection against Amyloid-beta Toxicity
11:30 AM - 07:00 PM	Abstract	189 - Mutational Analysis of AARS2 in Japanese Patients with Adult-Onset Leukoencephalopathy Lacking CSF1R Mutation Naomi Mezaki
11:30 AM - 07:00 PM	Abstract	190 - Identification and Functional Assay of Novel CSF1R Mutations in Patients with Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia Takeshi Miura
11:30 AM - 07:00 PM	Abstract	191 - Tau-related dysfunction of BRCA1 lead to reduced neuronal plasticity in Alzheimer's disease Tatsuo Mano, MD, PhD
11:30 AM - 07:00 PM	Abstract	192 - Measuring the Contributions of Heritable and Non-Heritable Risk Factors to Alzheimer Disease Age-at-Symptomatic-Onset in Adult Children of Affected Parents Gregory S. Day, MD, MSc, FAAN
11:30 AM - 07:00 PM	Abstract	193 - Clinical and neuropsychological features of a family with a novel PSEN-1 variant (I416T)
11:30 AM - 07:00 PM	Abstract	194 - Genome-wide Association Study Based on A/T/N System Identifies New Susceptibility Loci for Alzheimer's Disease Chenchen Tan, MD
11:30 AM - 07:00 PM	Abstract	195 - African Haplotypic Background Mitigates the Effect of APOE e4 Risk Allele in Alzheimer Disease
11:30 AM - 07:00 PM	Abstract	196 - TREM2 P.Arg47His Is Not Associated With Late-Onset Alzheimer's Disease In A Tunisian Population
11:30 AM - 07:00 PM	Abstract	197 - In vitro, In vivo and cerebrospinal fluid studies implicate decreased ABCA-1 activity with APOE4
11:30 AM - 07:00 PM	Abstract	198 - Case Report: SPG4-related cognitive decline in a patient with deletion of exons 5-17 Elizabeth A. Coffee, MD
11:30 AM - 07:00 PM	Abstract	199 - NA
11:30 AM - 07:00 PM	Abstract	200 - NA
11:30 AM - 07:00 PM	Abstract	201 - Characterizing Stroke in Transgender Adults - a San Francisco General Hospital Study Sara LaHue, MD
11:30 AM - 07:00 PM	Abstract	202 - The Role of Acute versus Ever Use of Cocaine in Ischemic Stroke of Young Adults Sleiman El Jamal, MD
11:30 AM - 07:00 PM	Abstract	203 - Code 420: A case series of accidental marijuana ingestion masquerading as acute stroke Katherine Werbaneth, MD
11:30 AM - 07:00 PM	Abstract	204 - Recreational Use Of Marijuana and Stroke: A Nationwide Outcome Study Urvish K. Patel
11:30 AM - 07:00 PM	Abstract	205 - Impact of Cocaine Use on Acute Ischemic Stroke Patients: Insights from Nationwide Inpatient Sample in the United States Zabeen K. Mahuwala, MD, FAAN
11:30 AM - 07:00 PM	Abstract	206 - History of Diabetes, Drug Abuse and Smoking Predicts Recurrence Rate of Ischemic Stroke in the Young Muhammad Ahmed, MD
11:30 AM - 07:00 PM	Abstract	207 - Continued Nationwide decline in Stroke related In-Hospital Mortality in United States
11:30 AM - 07:00 PM	Abstract	208 - Clinical Characteristics of Stroke Patients with Essential Thrombocytosis according to JAK2 mutation Joung-Ho Rha, MD, PhD
11:30 AM - 07:00 PM	Abstract	209 - Trauma due to Acute Ischemic Stroke: A Case Series Kevin A. Yeboah, MD
11:30 AM - 07:00 PM	Abstract	210 - Only hepatic fibrosis, not steatosis, assessed on transient elastography is an independent predictor of long-term mortality in patients with ischemic stroke. Minyoul Baik, Jr., MD
11:30 AM - 07:00 PM	Abstract	211 - Level of Consciousness at Discharge and Associations with Outcome After Ischemic Stroke Michael Reznik, MD
11:30 AM - 07:00 PM	Abstract	212 - Aphasia at Presentation Predicts Poor Functional Outcome After Acute Ischemic Stroke
11:30 AM - 07:00 PM	Abstract	213 - Cancer and Stroke - Presentations and Problems David Collas, MD
11:30 AM - 07:00 PM	Abstract	214 - Stroke in Teens
11:30 AM - 07:00 PM	Abstract	215 - Development and Validation of Graphical Displays for Reporting Acute Stroke Trials that Use a Patient-Centered Disability Outcome Primary Endpoint Ivie Tokunboh
11:30 AM - 07:00 PM	Abstract	216 - Classical Crossed Medullary Syndromes in Patients with Lateral Medullary Infarction Guillermo R. Delgado-Garcia, MD, MSc
11:30 AM - 07:00 PM	Abstract	217 - Etiologies, risk factors and functional outcomes of young stroke in a Taiwanese cohort Chelsea S. Chen
11:30 AM - 07:00 PM	Abstract	218 - Prevalence of HIV Infection Among Stroke Patients and its Association with Mortality in Southwestern Uganda
11:30 AM - 07:00 PM	Abstract	219 - Incidence of Ischemic and Hemorrhagic Stroke Amongst Asians in the United States Antonio Moya, MD, FAAN
11:30 AM - 07:00 PM	Abstract	220 - Leukoaraiosis & Metabolic Syndrome In Middle Age Egyption Ischemic Stroke Patients Wael O. Amer, MD
11:30 AM - 07:00 PM	Abstract	221 - Impact of Reactive Hyperglycemia on Stroke Severity and Outcome in Lagos, Nigeria Osigwe P. Agabi, MD
11:30 AM - 07:00 PM	Abstract	222 - Predictors of Stroke Recurrence at Lagos University Teaching Hospital,Nigeria. Osemwegie Nosakhare, MBBS
11:30 AM - 07:00 PM	Abstract	223 - Clinical characteristics of borderzone infarction in Egyptian population
11:30 AM - 07:00 PM	Abstract	224 - Neurovascular Protective Effects of Remote Ischemic Preconditioning in Acute Ischemic Stroke Model Farris Taha, MD
11:30 AM - 07:00 PM	Abstract	225 - Functional Remapping of the Mouse Somatosensory Cortex After Ischemic Stroke William Zeiger, MD, PhD
11:30 AM - 07:00 PM	Abstract	226 - Multimodal Imaging of White Matter Inflammation in a Rat Model of Striatal Ischemic Stroke Alexander Levit
11:30 AM - 07:00 PM	Abstract	227 - Blockade of Soluble Epoxide Hydrolase Attenuates Post-Ischemic Neuronal Hyperexcitation and Confers Resilience Against Stroke with TrkB Activation
11:30 AM - 07:00 PM	Abstract	228 - Characterizing the Neuroinflammatory Response of Focal Ischemic Stroke in the Rat Insular Cortex
11:30 AM - 07:00 PM	Abstract	229 - Association of plasma D-dimer and B-type natriuretic peptide levels with stroke mechanism, severity, and outcome Hyun-Wook Nah, MD
11:30 AM - 07:00 PM	Abstract	230 - Role Of Blood Biomarkers In Differentiating Ischemic Stroke and Intracerebral Hemorrhage Rohit Bhatia, MD, MBBS, DM
11:30 AM - 07:00 PM	Abstract	231 - Circulating inflammatory biomarkers are related to cerebrovascular disease in a non-demented elderly population Nicole Schupf, PhD, DrPH
11:30 AM - 07:00 PM	Abstract	232 - Diapedetic Potential of Monocytes in Complexes with Platelets Correlates with Clinical Outcome after Stroke Maria Lukasik, MD, PhD
11:30 AM - 07:00 PM	Abstract	233 - Multiple Biomarkers for the Prediction of Stroke Outcomes: Findings from a Cohort of 792 Patients with Ischemic Stroke in a University Teaching Hospital Zuolu Liu, MD
11:30 AM - 07:00 PM	Abstract	234 - Role Of Blood Biomarkers In Predicting Outcomes After Acute Stroke
11:30 AM - 07:00 PM	Abstract	235 - Marked Leukocytosis on Presentation with Acute Ischemic Stroke -- What Does it Mean? Matthew Broderick, MD
11:30 AM - 07:00 PM	Abstract	236 - Admission white blood cell count is associated with stroke severity and outcome independent of acute infarct size Arooshi Kumar, MD, Anne-Katrin Giese, MD
11:30 AM - 07:00 PM	Abstract	237 - Can S100b, IL 6 And BNP Predict Functional Neurological Outcome In Intracerebral Hemorrhage? Mohammed A. ElSherif, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	238 - Role of Copeptin as a Biomarker for Predicting Outcome after Spontaneous Intracerebral Hemorrhage: A Prospective Cohort Study Shubham Misra, PhD
11:30 AM - 07:00 PM	Abstract	239 - Role of Blood Based Biomarkers for Predicting Outcome after Spontaneous Intracerebral Hemorrhage: Findings from a Multi-Centric Prospective Cohort Study Kameshwar Prasad, MD
11:30 AM - 07:00 PM	Abstract	240 - A Combination of Three Repurposed Drugs Administered at Reperfusion as a Promising Therapy for Ischemic Stroke
11:30 AM - 07:00 PM	Abstract	241 - Molecular Genetic Features Of Polymorphism Of The Gene Col4a1 Rs605143 G / A In The Development Of Pathological Deformations Of Cerebral Vessels In Patients With Migraine Helena Gossye
11:30 AM - 07:00 PM	Abstract	242 - The Cerebral Straight and Narrow: A Case Illustration of Moyamoya Syndrome in the Setting of the ACTA-2 Gene Mutation Malcolm L. McDonald
11:30 AM - 07:00 PM	Abstract	243 - Rare Presentation of Malignant Myxomatous Aneurysms with PRKAR1A gene mutation Usman Shehzad, MD
11:30 AM - 07:00 PM	Abstract	244 - Molecular - Genetic Features Of The Gene Of Vasculoendothelial Growth Factor (C634G VEGFA) In The Deformations Of Cerebral Vessels Helena Gossye
11:30 AM - 07:00 PM	Abstract	245 - PAI-1 polymorphism and stroke in pregnancy Mary O. Hollist, DO
11:30 AM - 07:00 PM	Abstract	246 - Ring-enhancing lesions, stroke and vascular retinopathy associated with a novel TREX1 mutation Marcus Cimino, MD
11:30 AM - 07:00 PM	Abstract	247 - Systemic Response to Rupture of Intracranial Aneurysms Analyzed with Whole-transcriptome Sequencing Joanna Pera, MD
11:30 AM - 07:00 PM	Abstract	248 - Association of Transforming growth Factor-?1 gene C509T, G800A and T869C Polymorphisms with Intracerebral Hemorrhage in North Indian Population: A Case-Control Study Shubham Misra, PhD
11:30 AM - 07:00 PM	Abstract	249 - Role Of Pharmacogenetics and Pharmacodynamics On The Antiplatelet Effect Of Clopidogrel In North Indian Ischemic Stroke Patients Dheeraj Khurana, MD
11:30 AM - 07:00 PM	Abstract	250 - Association between Tumor necrosis factor-alpha (-308G/A, +488G/A, -857C/T and -1031 T/C) gene polymorphisms and risk of ischemic stroke in north Indian population: A case-control study Pumanshi Talwar
11:30 AM - 07:00 PM	Abstract	251 - Safety and Feasibility of Telestroke in the Prehospital Emergency Medical Services Setting - The REACHOUT Project Muhammad Adeel Saleemi, MBBS
11:30 AM - 07:00 PM	Abstract	252 - Pre-arrival RACE Score-Based Hospital Bypass Protocol Improves Treatment Time Efficiencies
11:30 AM - 07:00 PM	Abstract	253 - Correlation between evaluation and documentation of neurologic deficit by EMS and ED of patients with acute ischemic stroke Haitham Hussein, MD, FAAN
11:30 AM - 07:00 PM	Abstract	254 - A Prospective Validation of Stroke Network Of Wisconsin (SNOW) Scale Kessarin Panichpisal, MD
11:30 AM - 07:00 PM	Abstract	255 - Safety of intravenous thrombolysis in telestroke and impact of an acute stroke training curriculum Tarun Girotra, MD
11:30 AM - 07:00 PM	Abstract	256 - NA
11:30 AM - 07:00 PM	Abstract	257 - NA
11:30 AM - 07:00 PM	Abstract	258 - NA
11:30 AM - 07:00 PM	Abstract	259 - Baroreflex Sensitivity in Patients with Intractable Generalized Tonic Clonic Seizures versus Partial Seizures Behnaz Esmaeili, MD
11:30 AM - 07:00 PM	Abstract	260 - Evaluation of Dual Pathology Among Drug Resistant Epileptic Patients With Hippocampal Sclerosis
11:30 AM - 07:00 PM	Abstract	261 - A New Database Platform for Clinical and Genetic Investigation of Epilepsies and the New ILAE Classification David A. Discua
11:30 AM - 07:00 PM	Abstract	262 - Initial Presentations and Surgical Outcomes of Pediatric Patients with Neurovascular Lesions Janani Kassiri, MD, PhD
11:30 AM - 07:00 PM	Abstract	263 - Comparing the Clinical Profile and Seizure Control between Focal and Generalized Seizures in Adult Nigerian Patients with Epilepsy. Chindo B. Mallum, MD
11:30 AM - 07:00 PM	Abstract	264 - A Fatal Case of Mistaken Identity: Brugada Syndrome Masquerading as Seizure Disorder Claribel D. Wee, MD
11:30 AM - 07:00 PM	Abstract	265 - Impact of Seizures in Temporal Lobe Epilepsy on Cognitive Functions and Imaging Features Gyujoon Hwang
11:30 AM - 07:00 PM	Abstract	266 - Clinical Significance of Bilateral Failures on Wada Memory Testing Iffat Ara Suchita, MD
11:30 AM - 07:00 PM	Abstract	267 - Seizure-induced Behavioral and Autonomic Arousal Localizes to the Anterior Cingulate Gyrus: Network Dynamics and Underlying Mechanism Harshad Ladha, MD
11:30 AM - 07:00 PM	Abstract	268 - Does A Drug Refractory Epilepsy (DRE) diagnosis impact time to seizures in the Epilepsy Monitoring Unit (EMU) Brian Toh
11:30 AM - 07:00 PM	Abstract	269 - The Role Of Immunoreactivity Of Neurotropic Autoantibodies And Neuromediators In The Pathogenesis Of Symptomatic And Idiopathic Epilepsy Marufjon Salokhiddinov, MD
11:30 AM - 07:00 PM	Abstract	270 - Epilepsy as a Dynamic Disease: Modeling Seizure Burden Based On Transitions Between Seizure Risk States Sharon Chiang, MD, PhD
11:30 AM - 07:00 PM	Abstract	271 - Effect of Anesthesia on Electrocorticography for localization of Epileptic Focus: Literature Review and Future Directions
11:30 AM - 07:00 PM	Abstract	272 - Can We Predict the prognosis in patients with Acute Symptomatic Seizure? A Prognostic model: A Retrospective study from a developing nation Gopal K. Dash, DM
11:30 AM - 07:00 PM	Abstract	273 - Characterization of a Novel Knock-in Mouse Model of KCNT1 Epileptic Encephalopathy Lisseth E. Burbano, MD, PhD
11:30 AM - 07:00 PM	Abstract	274 - NLRP1 Inflammasome is Activated in Patients with Medial Temporal Lobe Epilepsy and Contributes to Neuronal Pyroptosis in Amygdala Kindling- induced Rat Model Chenchen Tan, MD
11:30 AM - 07:00 PM	Abstract	275 - Autophagy in Juvenile Myoclonic Epilepsy (JME)
11:30 AM - 07:00 PM	Abstract	276 - NADPH oxidase inhibitor attenuated increased seizure susceptibility after systemic inflammation Wan-Yu Huang
11:30 AM - 07:00 PM	Abstract	277 - A role of GPR55 in the antiepileptic properties of cannabidiol (CBD) Xiaoyang Lan, PhD
11:30 AM - 07:00 PM	Abstract	278 - Variation in Cortical Impact Augments Epileptogenesis in Rat Model of Traumatic Brain Injury. Shammy Chandel
11:30 AM - 07:00 PM	Abstract	279 - Protective effects of protocatechuic acid against seizure-induced neuronal death in the pilocarpine-induced status epilepticus rat model Dong Jin Shin, MD
11:30 AM - 07:00 PM	Abstract	280 - Association Between Occurrence of Hippocampal Spindles and Hippocampal Interictal Spiking. Kseniia K. Kriukova
11:30 AM - 07:00 PM	Abstract	281 - Majority of Epilepsy Mutations are in Genes with Therapeutic Associations
11:30 AM - 07:00 PM	Abstract	282 - Genotype and Phenotype Correlation in Patients with Comorbid Epilepsy and Intellectual Disability Mohamed Taha, MD
11:30 AM - 07:00 PM	Abstract	283 - Screening of PI3K-AKT-mTOR pathway genes in focal cortical dysplasias in a clinical setting
11:30 AM - 07:00 PM	Abstract	286 - Prevalence and Impact of Consanguinity in Patients with Mesial Temporal Sclerosis in Saudi Population Khalid S. Alqadi, MD
11:30 AM - 07:00 PM	Abstract	287 - Refractory Status Epilepticus and Chronic Kidney Disease in a Large Pedigree Due to a Variant in the Mitochondrial Encoded tRNA Phenylalanine (MT-TF) Gene James Ellis
11:30 AM - 07:00 PM	Abstract	288 - Analysis of 234 Epilepsy Genes for Sequence and Copy Number Variants Using Next Generation Sequencing Zhenyuan Wang, PhD
11:30 AM - 07:00 PM	Abstract	289 - Genetic Testing has taken out Guesswork: Cases of Familial and Non-familial Benign Infantile Epilepsy Associated with PRRT2 gene mutations. Yoshimi Hisamoto, MD
11:30 AM - 07:00 PM	Abstract	290 - NA
11:30 AM - 07:00 PM	Abstract	291 - NA
11:30 AM - 07:00 PM	Abstract	292 - NA
11:30 AM - 07:00 PM	Abstract	293 - NA
11:30 AM - 07:00 PM	Abstract	294 - NA
11:30 AM - 07:00 PM	Abstract	295 - EEG Patterns in Routine Polysomnography in Childhood and Risk of Epilepsy Robert C. Stowe, MD
11:30 AM - 07:00 PM	Abstract	296 - New Onset Refractory Status Epilepticus in Pediatric Population: A Single Tertiary Center Experience Khalil Husari, MD
11:30 AM - 07:00 PM	Abstract	297 - Cognitive, Linguistic and Behavioral Characteristics of Children with Comorbid Autism Spectrum Disorder and Epilepsy Louisa Kalsner, MD
11:30 AM - 07:00 PM	Abstract	298 - Evaluation of new onset seizures presenting to the Pediatric Emergency Department(ED). A quality improvement study based on the AAN, CNS and AES practice parameters (2010). Nitish Chourasia, MD
11:30 AM - 07:00 PM	Abstract	299 - Cognitive Outcomes In Children With Infantile Spasms: Successful Treatment Response Is Beneficial Regardless Of Etiology Nonita Mittal, MBBS
11:30 AM - 07:00 PM	Abstract	300 - The clinical and electroencephalographic spectrum of ESES (Encephalopathy with status epilepticus in sleep) in Indian children Priyanka Madaan
11:30 AM - 07:00 PM	Abstract	301 - Long-Term Prognostic Patterns In Pediatric Epilepsy: A Review Of Literature. Kushal Naik
11:30 AM - 07:00 PM	Abstract	302 - Rectal Administration of Vigabatrin Achieves Higher Plasma Concentration than Oral Administration.
11:30 AM - 07:00 PM	Abstract	303 - Utilizing Quality Improvement Strategies to Increase Continuous EEG Monitoring in Critically Ill Pediatric Patients with Persistent Encephalopathy Following Status Epilepticus Asri Yuliati, MD
11:30 AM - 07:00 PM	Abstract	304 - Expanding the clinical spectrum of the rare epilepsy syndrome of Benign Infantile Focal Epilepsy with Midline Spikes (BIMSE) Reema Choudhry, MD
11:30 AM - 07:00 PM	Abstract	305 - Drug-Resistant Epilepsy and Neurodevelopmental Disabilities in Randomized Controlled Trials of Therapeutic Devices Lydia J. Bernhardt
11:30 AM - 07:00 PM	Abstract	306 - The Spectrum of Myelopathies in Children: Beyond Idiopathic Transverse Myelitis Laura S. Munoz-Arcos, MD
11:30 AM - 07:00 PM	Abstract	307 - Cerebrospinal fluid (CSF) Neurofilament and CXCL-13 Levels in Children with Demyelinating Disease Maria M. Galardi, MD
11:30 AM - 07:00 PM	Abstract	308 - Pediatric and Adult MS: A Longitudinal Multimodal MRI Study to Explore the Substrates of the Different Clinical Courses Ermelinda De Meo
11:30 AM - 07:00 PM	Abstract	309 - Chitinase 3-like 1 and Neurofilament Light Chain Predict Pediatric Demyelination Magnus Spangsberg Boesen, MD
11:30 AM - 07:00 PM	Abstract	310 - CT Scan Findings in Microcephaly Cases During 2015-2016 Zika Outbreak: A Cohort Study
11:30 AM - 07:00 PM	Abstract	311 - Use of Induction Immunotherapy Plus Rituximab for the Treatment of Pediatric Opsoclonus-Myoclonus Syndrome Colin Wilbur, MD
11:30 AM - 07:00 PM	Abstract	312 - To determine the prevalence of neurologic syndromes, intellectual disability, abnormal behavior and sleep related problems in HIV infected children
11:30 AM - 07:00 PM	Abstract	313 - Autoimmune encephalitis in children: Clinical profile and outcome from a single tertiary care centre in India Sheffali Gulati, MD, FAMS, FIAP, FNASc, FIANs
11:30 AM - 07:00 PM	Abstract	314 - Radiological Findings and Neurological Disorders in Microcephaly Cases Related to Zika Virus: A Cohort Study
11:30 AM - 07:00 PM	Abstract	315 - Gait variability is related to attention and information processing speed in adolescents with multiple sclerosis Shay Menascu, MD
11:30 AM - 07:00 PM	Abstract	316 - A Case of Cognitive and Behavioral Decline leading to Onset of Pediatric Onset Multiple Sclerosis Janet Elgallab, MD
11:30 AM - 07:00 PM	Abstract	317 - A Case Series of Acute Flaccid Myelitis in Pediatric Patients Lydia Marcus, MD
11:30 AM - 07:00 PM	Abstract	318 - Imaging of the Mechanisms of Thalamic Damage in Pediatric Multiple Sclerosis Ermelinda De Meo
11:30 AM - 07:00 PM	Abstract	319 - Miller Fisher Syndrome in a Case of Identical Twins Tayyba Anwar, MD
11:30 AM - 07:00 PM	Abstract	320 - Pediatric Acute Flaccid Myelitis: A Case Series Alison L. Christy, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	321 - Chiari malformations associated with transverse myelitis: are these myelopathies truly inflammatory? Eliza M. Gordon-Lipkin, MD
11:30 AM - 07:00 PM	Abstract	322 - Ambulatory function and fatigue in nusinersen-treated children with spinal muscular atrophy. Jacqueline Montes, PT, EdD, NCS
11:30 AM - 07:00 PM	Abstract	323 - Safety profile of abobotulinumtoxinA (Dysport®) for lower limb spasticity: Pooled analysis of controlled clinical trials Ann H. Tilton, MD, FAAN
11:30 AM - 07:00 PM	Abstract	324 - Safety and Efficacy of Nusinersen in Infants/Children with Spinal Muscular Atrophy (SMA): Part 1 of the Phase 2 EMBRACE Study Perry Shieh, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	325 - Meta-Analysis of Deflazacort vs Prednisone/Prednisolone in Patients with Duchenne Muscular Dystrophy Basil T. Darras, MD
11:30 AM - 07:00 PM	Abstract	326 - Pediatric Myasthenia Gravis After Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (1990-2017) Rajanigandhi Hanumanthu, MD
11:30 AM - 07:00 PM	Abstract	327 - Evaluation of Childhood Weakness: Utilization of a Web-Based Educational Tool childmuscleweakness.org
11:30 AM - 07:00 PM	Abstract	328 - Predicting Ambulatory Aid Needs with Disease Progression in Charcot-Marie-Tooth Disease Sindhu Ramchandren, MD
11:30 AM - 07:00 PM	Abstract	329 - Design of a Phase 3 Trial to Evaluate the Long-Term Efficacy and Safety of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy Panayiota Trifillis
11:30 AM - 07:00 PM	Abstract	330 - Assessment of Practice Patterns and Knowledge of Pathophysiology for Spinal Muscular Atrophy Among Neurologists John Maeglin
11:30 AM - 07:00 PM	Abstract	331 - Slope Analysis of 6-Minute Walk Dstance as an Alternative Method to Determine Treatment Effect in Trials in Duchenne Muscular dystrophy Panayiota Trifillis
11:30 AM - 07:00 PM	Abstract	332 - Tolerability of Eteplirsen for Duchenne Muscular Dystrophy in the Youngest Reported Patient Treated With This Therapy Sonam C. Bhalla, MD
11:30 AM - 07:00 PM	Abstract	333 - Cervical Puncture to Deliver Nusinersen in Patients with Spinal Muscular Atrophy and no Lumbar Access Aravindhan Veerapandiyan, MD
11:30 AM - 07:00 PM	Abstract	334 - A unique presentation of rapidly fluctuating symptoms in a child diagnosed with Congenital Myasthenic Syndrome due to RAPSN mutation. Ashutosh Kumar, MD
11:30 AM - 07:00 PM	Abstract	335 - Focal Myositis of the Iliopsoas in a Young Girl with Recurrent Symptoms: A Case Report Stephanie Manberg, DO
11:30 AM - 07:00 PM	Abstract	336 - Unexpected Neuromuscular Diagnoses from Chromosomal Microarrays Rebecca Luke, DO
11:30 AM - 07:00 PM	Abstract	337 - NA
11:30 AM - 07:00 PM	Abstract	338 - NA
11:30 AM - 07:00 PM	Abstract	339 - Seizure Risk From Intraoperative Motor Evoked Potential Stimulation Viet Nguyen, MD
11:30 AM - 07:00 PM	Abstract	340 - Mesial Temporal Sclerosis (MTS) Undetected by MRI of the Brain Miad F. Albalawi, Jr., MD
11:30 AM - 07:00 PM	Abstract	341 - Long Term Effects of Vagal Nerve Stimulation on Seizure Control and Quality of Life Justin V. Abraham, MD
11:30 AM - 07:00 PM	Abstract	342 - Unilateral deep brain stimulation masks undiagnosed epilepsy in a Parkinson's Disease patient: A Case Report Alexis M. Taylor, MD
11:30 AM - 07:00 PM	Abstract	343 - EEG Cap Placement for Expedited Identification of Non-Convulsive Status Epilepticus Jake McKay, MD
11:30 AM - 07:00 PM	Abstract	344 - Analyzing Phenotypes Using Artificial Intelligence Tools in Subgroups of Absence and Myoclonic Epilepsies Reyna M. Duron, MD
11:30 AM - 07:00 PM	Abstract	345 - Hypertension and heart disease are independently associated with development of brain atrophy in multiple sclerosis patients. A 5-year longitudinal study Dejan Jakimovski, MD, PhD
11:30 AM - 07:00 PM	Abstract	346 - The Impact of Socioeconomic Status on Treatment Choice in Patients with Multiple Sclerosis. Saul Reyes, MD
11:30 AM - 07:00 PM	Abstract	347 - Vitamin D and physical activity in multiple sclerosis Florian Deisenhammer, MD
11:30 AM - 07:00 PM	Abstract	348 - Depression Severity Among Multiple Sclerosis Patients In Saudi Arabia-Cross Sectional Study
11:30 AM - 07:00 PM	Abstract	349 - Vitamin B12 and its impact on Multiple Sclerosis Type and Severity Shymaa Hussain, MBBS
11:30 AM - 07:00 PM	Abstract	350 - Cesarean delivery and artificial lactation are associated with an earlier age of disease onset in multiple sclerosis Vittorio Martinelli
11:30 AM - 07:00 PM	Abstract	351 - Distinct Effects of Obesity and Vitamin D on Risk of Multiple Sclerosis: A Mendelian Randomization Study Adil Harroud, MD
11:30 AM - 07:00 PM	Abstract	352 - Vitamin D Levels and Clinical and OCT measures in Progressive Multiple Sclerosis Justin Abbatemarco, MD
11:30 AM - 07:00 PM	Abstract	353 - Longer Sleep Duration is Linked to Preserved Cortical Gray Matter Volume in Early MS Michelle Fabian, MD, FAAN
11:30 AM - 07:00 PM	Abstract	354 - Risk Factors Associated with Multiple Sclerosis in Bogotá, Colombia. Jaime Toro, MD, FAAN
11:30 AM - 07:00 PM	Abstract	355 - The Gut Microbiome in Relapsing Multiple Sclerosis Patients Compared to Controls. Raffaella Umeton, MD, PhD, MMSc
11:30 AM - 07:00 PM	Abstract	356 - Fecal Microbial Transplantation in Multiple Sclerosis: trial design. Ana Cristina W. Dos Santos
11:30 AM - 07:00 PM	Abstract	357 - Gut microbiota and metagenomic diversity in Clinical Isolated Syndrome
11:30 AM - 07:00 PM	Abstract	358 - A Paleolithic Diet-Based Intervention Decreases Multiple Sclerosis Fatigue via Lipid Profile Changes Murali Ramanathan, PhD
11:30 AM - 07:00 PM	Abstract	359 - Stress-induced Brain Activity, Brain Atrophy, and Clinical Disability in Multiple Sclerosis Lil-Antonia Meyer-Arndt, MD, PhD
11:30 AM - 07:00 PM	Abstract	360 - Case Series of Four High School Football Players with Multiple Sclerosis Cynthia X. Wang, MD
11:30 AM - 07:00 PM	Abstract	361 - Nutrition in the First Year Following the Diagnosis of Multiple Sclerosis Yujie Wang, MD
11:30 AM - 07:00 PM	Abstract	362 - Sarcoidosis Presenting as Intramedullary Spinal Cord Lesions Prateek Thatikunta, MD
11:30 AM - 07:00 PM	Abstract	363 - When It's Not Multiple Sclerosis: Progressive White Matter Lesions with Inflammation Julia N. Bucklan, DO
11:30 AM - 07:00 PM	Abstract	364 - Comorbidity in ultiple Sclerosis is associated with Diagnostic Delays and Increased Mortality Anja Thormann, MD, PhD
11:30 AM - 07:00 PM	Abstract	365 - Population-Based Prospective Cohort of RRMS Patients Who Declined or Delayed Disease-Modifying Therapy Abdulaziz S. Al Sultan, MD
11:30 AM - 07:00 PM	Abstract	366 - Assessment of Relative Importance of Disease Modifying Treatment (DMT) Attributes in Multiple Sclerosis (MS) Patients Tobias Sejbaek, MD, PhD
11:30 AM - 07:00 PM	Abstract	367 - Late Onset Fabry Disease: A Mimicker of CNS Demyelinating Disease Subhendu Rath, MBBS
11:30 AM - 07:00 PM	Abstract	368 - The phenotype of Argentinean Multiple Sclerosis patients is similar to Multiple Sclerosis patients from other regions and has remained stable over the past decade. Mariano Marrodan, MD
11:30 AM - 07:00 PM	Abstract	369 - Impact of Gender on 30-day Readmission After Primary Admissions for Multiple Sclerosis: A Nationwide Readmission Database Analysis
11:30 AM - 07:00 PM	Abstract	370 - Residual disability of acute severe multiple sclerosis relapses Anat Achiron, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	371 - Clinical and Immunologic Characterization of MRI-Defined Phenotypes in Multiple Sclerosis: a Longitudinal Study Christopher Hemond, MD
11:30 AM - 07:00 PM	Abstract	372 - Retinal Vasculopathy with Cerebral Leukoencephalopathy (RVCL): A Rare Familial Mimic of Tumefactive Multiple Sclerosis (MS) Asaff Harel, MD
11:30 AM - 07:00 PM	Abstract	373 - An Extremely Aggressive case of Marburg's Disease Jose Avila-Ornelas, MD
11:30 AM - 07:00 PM	Abstract	374 - Spectrum of Peripheral Facial Involvement in Central Demyelinating Diseases Elias Samaha, MD
11:30 AM - 07:00 PM	Abstract	375 - Impact of age at relapse on recovery: An EDSS-recovery model for clinical trials Burcu Zeydan, MD
11:30 AM - 07:00 PM	Abstract	376 - Predictors of Vocational Status Among Persons with Multiple Sclerosis Sarah A. Morrow, MD, MSC, FRCPC, FAAN
11:30 AM - 07:00 PM	Abstract	377 - Relevance of Age and Cerebrospinal Fluid Measures in Multiple Sclerosis associated with seizures Shitiz K. Sriwastava, MBBS
11:30 AM - 07:00 PM	Abstract	378 - Bone Microarchitecture and Bone Mineral Density in Multiple Sclerosis Anna Olsson
11:30 AM - 07:00 PM	Abstract	379 - Impact of multiple comorbidities on EDSS at presentation in patients with multiple sclerosis: A cross-sectional study. Faisal A. Alsallom, MD
11:30 AM - 07:00 PM	Abstract	380 - Estimated prevalence of secondary progressive multiple sclerosis in the USA and Europe: results from a systematic literature search
11:30 AM - 07:00 PM	Abstract	381 - Erdheim-Chester Disease in the Brainstem Mimicking Tumefactive Demyelination. Maria del Pilar Guillermo Prieto Eibl, MD
11:30 AM - 07:00 PM	Abstract	382 - Differential Expression of Alternative Splicing Variants in Individuals with Relapsing-Remitting Multiple Sclerosis Michael Hecker, PhD
11:30 AM - 07:00 PM	Abstract	383 - Development of Multiple Sclerosis relapse flare after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, [1987-2017].
11:30 AM - 07:00 PM	Abstract	384 - EMPLOYMENT SITUATION IN BRAZILIAN PATIENTS DIAGNOSED WITH MULTIPLE SCLEROSIS Denis B. Bichuetti, MD
11:30 AM - 07:00 PM	Abstract	385 - Impact of Age on 30-day Readmission After Primary Admission for Multiple Sclerosis: A Nationwide Readmission Databse Analysis
11:30 AM - 07:00 PM	Abstract	386 - The Prevalence and Special Characteristic of Multiple Sclerosis that Begins in Older Adults
11:30 AM - 07:00 PM	Abstract	387 - Does Co-morbidity with Familial Mediterranean Fever change the course of Multiple Sclerosis? Aksel Siva, MD
11:30 AM - 07:00 PM	Abstract	388 - Protective role of Multiple Sclerosis in Stroke; Analysis of a large national data base
11:30 AM - 07:00 PM	Abstract	389 - A Whole-Exome Sequencing Study In Multiple Sclerosis Multiplex Families Elisabetta Mascia
11:30 AM - 07:00 PM	Abstract	390 - The Saudi Arabian National Multiple Sclerosis Registry (NMSR): Initial Results Saudi MS Registry Study Group* Mohammed A. Al-Jumah, MD, MBBS, FAAN
11:30 AM - 07:00 PM	Abstract	391 - Demyelination and Neurodegeneration along the Visual Pathway are more prominent in Secondary Progressive than Primary Progressive Multiple Sclerosis.
11:30 AM - 07:00 PM	Abstract	392 - Regional thalamic volumes preferentially correlate with extra-thalamic white matter injury and clinical disability in multiple sclerosis subtypes Kedar Mahajan, MD, PhD
11:30 AM - 07:00 PM	Abstract	393 - Predictors of Conversion to Secondary Progressive Multiple Sclerosis in Patients With Relapsing-Remitting Multiple Sclerosis Davorka Tomic
11:30 AM - 07:00 PM	Abstract	394 - Predicting Physical and Mental Disability in Patients with Multiple Sclerosis: a Longitudinal Analysis of Electronic Health Records. Farren Briggs, PhD
11:30 AM - 07:00 PM	Abstract	395 - New versus old: Implications of diagnostic criteria for Relapsing Remitting Multiple Sclerosis Nuala McNicholas, MBBS
11:30 AM - 07:00 PM	Abstract	396 - Familial Multiple Sclerosis: An Epidemiological Study in Pontevedra, Spain. Ana Rodriguez Regal
11:30 AM - 07:00 PM	Abstract	397 - Increased Risk of Ischemic Stroke Associated with Untreated Multiple Sclerosis: A Nationwide Case-Control Population-Based Study. Asad Ikram, MD, MBBS
11:30 AM - 07:00 PM	Abstract	398 - The North American Registry for Care and Research in Multiple Sclerosis Anne H. Cross, MD, FAAN
11:30 AM - 07:00 PM	Abstract	399 - Long-term disability outcomes in relapsing-remitting multiple sclerosis: A 10-year follow-up study Jelena Drulovic
11:30 AM - 07:00 PM	Abstract	400 - Patient Perspectives on Discontinuing Disease Modifying Therapies in the NARCOMS Registry Marisa P. McGinley, DO
11:30 AM - 07:00 PM	Abstract	401 - Astrocyte Transciptomics in EAE Lead to Cholesterol Homeostasis as a New Treatment Target Noriko Itoh, MS
11:30 AM - 07:00 PM	Abstract	402 - Longitudinal Diffusion Tensor Imaging in Theiler's Murine Encephalomyelitis Virus Driven Mouse Model of MS Reveals White Matter Change Ely G. Cuberos Paredes
11:30 AM - 07:00 PM	Abstract	403 - Interaction of Normal and Antineuronal IgGs with Neurons in Rat Brain Slice Cultures: Comparison of IgG Uptake, Clearance, Intraneuronal Binding to Target Antigens, and Production of Neuronal Death John E. Greenlee, MD, FAAN
11:30 AM - 07:00 PM	Abstract	404 - Estrogen Receptor ? Ligand Acts on Two Pathways Within the CNS to Mediate Neuroprotection in the MS Model
11:30 AM - 07:00 PM	Abstract	405 - Cellular Senescence Correlates with Demyelination, Brain Atrophy and Motor Impairment in a Model of Multiple Sclerosis
11:30 AM - 07:00 PM	Abstract	406 - IL-11 antagonist suppresses Th17 cells-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis Xin Zhang
11:30 AM - 07:00 PM	Abstract	407 - IL-11-stimulated Encephalitogenic CD4+ Cells Induce Aggressive RREAE, Mediated via Th17, CD8+, CD19+ Cells and Neutrophils' Migration to CNS in Passive Transfer RREAE Elizabeth Davis
11:30 AM - 07:00 PM	Abstract	408 - Teriflunomide (Aubagio®) decreases microglial density in Theiler's Murine Encephalomyelitis Virus model of demyelination: Histological approach in combination with neuroimaging Suyog U. Pol, PhD
11:30 AM - 07:00 PM	Abstract	409 - BDNF is necessary for neuronal activity-regulated oligodendrogenesis Anna Geraghty
11:30 AM - 07:00 PM	Abstract	410 - Effect of Subcutaneous vs Intravenous Chronic Treatment with an Anti-CD20 Antibody on B-, T- and Myeloid Lymphocyte Subsets in Blood, Lymph Nodes and Spleen of C57BL/6 Mice Anna Schubart
11:30 AM - 07:00 PM	Abstract	411 - Complete Resolution of Clinical Signs and Synergism of the Combination Ponesimod-dimethyl Fumarate in Rat Models of Multiple Sclerosis Laetitia Pouzol
11:30 AM - 07:00 PM	Abstract	412 - Cerebrospinal Fluid Derived from Primary Progressive MS Delays Remyelination after Lysolecithin-induced Demyelination Nathan Kung
11:30 AM - 07:00 PM	Abstract	413 - Dietary Conjugated Linoleic Acid Supplementation Modulates CNS Autoimmunity
11:30 AM - 07:00 PM	Abstract	414 - Passive transfer of human aquaporin-4 IgG autoantibodies causes complement-independent spinal cord immunopathologies in mice Koon Ho Chan, MD, MBBS
11:30 AM - 07:00 PM	Abstract	415 - Neurocognitive Correlates of Impaired Perceptual Decision-Making in MS and their Link to Quality of Life Martin Weygandt, PhD
11:30 AM - 07:00 PM	Abstract	416 - Treatment satisfaction and illness perception in MS patients
11:30 AM - 07:00 PM	Abstract	417 - Pain Network and Neuropsychological Profile in Multiple Sclerosis and Migraine Patients Claudio Gobbi, MD
11:30 AM - 07:00 PM	Abstract	418 - Neuroanatomical Correlates of Latent Variables Speed and Memory in Early Multiple Sclerosis Ilena George, MD
11:30 AM - 07:00 PM	Abstract	419 - Exploring Cannabis use by Patients with Multiple Sclerosis in a state where Cannabis is legal Laura J Weinkle, MS
11:30 AM - 07:00 PM	Abstract	420 - Screening of cognitive impairment in patients with multiple sclerosis (MS): the BICAMS short version for patient-centered care in small neurological institutions Iris Katharina Penner, PhD
11:30 AM - 07:00 PM	Abstract	421 - A new electronic and brief neuropsychological scale to detect cognitive impairment (CI) in patients with multiple sclerosis (MS): Validation study of the MS-COG-e scale Jose Meca Lallana, MD
11:30 AM - 07:00 PM	Abstract	422 - Effects of Live-Online Education on Multiple Sclerosis Disease Management: Changes in Patient Experience, Clinical Practice, Provider Knowledge and Competence Anne C. Roc, PhD
11:30 AM - 07:00 PM	Abstract	423 - Cognitive reserve is consistently related to cognitive performance in Multiple Sclerosis Alvino Bisecco
11:30 AM - 07:00 PM	Abstract	424 - Impact of Multiple Sclerosis on Employment and its Association with Anxiety, Depression, Fatigue and Sleep Disorders
11:30 AM - 07:00 PM	Abstract	425 - NA
11:30 AM - 07:00 PM	Abstract	426 - NA
11:30 AM - 07:00 PM	Abstract	427 - NA
11:30 AM - 07:00 PM	Abstract	428 - NA
11:30 AM - 07:00 PM	Abstract	429 - Skin coldness and painful cold: the common symptom in patients with clinically suspected small fiber neuropathy in Korea Eun Bin Cho, MD
11:30 AM - 07:00 PM	Abstract	430 - Is There A Relationship Between Exacerbated Diabetic Peripheral Neuropathy And Metformin? Mohammed A. ElSherif, MD, PhD, FAAN
11:30 AM - 07:00 PM	Abstract	431 - Brachial plexopathy after influenza vaccination in adults in the USA. A report from the CDC/FDA Vaccine Adverse Event Reporting System (1990-2017)
11:30 AM - 07:00 PM	Abstract	432 - Neuropathy with Dysarthria and Ophthalmoparesis Tekalign Burka, MD
11:30 AM - 07:00 PM	Abstract	433 - Use of Intravenous Immunoglobulin in Small Fiber Neuropathy associated with FGFR3 Ajal Dave, MD
11:30 AM - 07:00 PM	Abstract	434 - Isolated external ophthalmoplegia associated with IgG anti-GQ1b antibody Sunhee Kim, MD
11:30 AM - 07:00 PM	Abstract	435 - A case of remission from multifocal motor neuropathy following rituximab Natalia Gonzalez, MD
11:30 AM - 07:00 PM	Abstract	436 - Late Onset TTR-related Familial Amyloid Polyneuropathy (FAP) in Two Patients with Acquired Demyelinating Features Nazila Rad, MD
11:30 AM - 07:00 PM	Abstract	437 - A Novel Report of Nivolumab-Induced Parsonage-Turner Syndrome Associated with Hourglass-like Constriction of the Anterior Interosseous Nerve Michael Porambo
11:30 AM - 07:00 PM	Abstract	438 - Acute Intermittent Porphyria: Sometimes DIfficult to Diagnose Yuri S. Macedo, MD
11:30 AM - 07:00 PM	Abstract	439 - Ganglioside Antibodies in Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) and its Variants Mithila Fadia, MBBS
11:30 AM - 07:00 PM	Abstract	440 - Cognitive Biases at Bedside Resulting in Diagnostic Error of Guillain-Barré Syndrome Rohit Gummi, MD
11:30 AM - 07:00 PM	Abstract	441 - Heterozygous Mutations of SH3TC2 as a Cause of HNPP Devin E. Prior, MD
11:30 AM - 07:00 PM	Abstract	442 - Reduction in Idiopathic Peripheral Neuropathy Diagnoses Using a Comprehensive EMR-based Laboratory Order Set Fang Bai, MD
11:30 AM - 07:00 PM	Abstract	443 - Brachial Plexopathy Post Transcatheter Arterial Chemoembolization Kavneet Kaur, MD
11:30 AM - 07:00 PM	Abstract	444 - Novel Mutation in KIF5A Causing Hereditary Spastic Paraplegia with Axonal Sensorimotor Neuropathy Mathieu Cuchanski, DO
11:30 AM - 07:00 PM	Abstract	445 - Eosinophilic Vasculitic Neuropathy As A Presentation Of Churg-Strauss Syndrome Sandeep Devarapalli, MD
11:30 AM - 07:00 PM	Abstract	446 - Outcome comparison of mechanically ventilated Guillain-Barre Syndrome versus Myasthenia Gravis in US Hospitals
11:30 AM - 07:00 PM	Abstract	447 - Guillain-Barre Syndrome as a Rare Initial Presentation of Systemic Lupus Erythematosus. Swathy Chandrashekhar, MD
11:30 AM - 07:00 PM	Abstract	448 - Rapidly Progressive POEMS Syndrome with Absent M protein in Serum or Urine, Normal Bone Survey, and Normal Non-targeted Bone Marrow Biopsy Payam Soltanzadeh, MD, FAAN
11:30 AM - 07:00 PM	Abstract	449 - Modifying Hyperglycemic Peripheral Nerve Injury Mark M. Stecker, MD, FAAN
11:30 AM - 07:00 PM	Abstract	450 - Rare Case of Ulnar Neuropathy Anai C. Hamasaki, MD
11:30 AM - 07:00 PM	Abstract	451 - Ustekinumab related CIDP in a patient with psoriatic arthritis Gamaleldin M. Osman, MD
11:30 AM - 07:00 PM	Abstract	452 - Proximal Motor Sensory Hereditary Neuropathy (HMSN-P) in a Peruvian Family with Japanese Ancestry Elison H. Sarapura Castro, MD
11:30 AM - 07:00 PM	Abstract	453 - Acute Motor Axonal Neuropathy (AMAN) presenting with truncal and appendicular ataxia Ashmanie Mahatoo, MD
11:30 AM - 07:00 PM	Abstract	454 - Needle Impedance-Electromyography (I-EMG): a New Technique for the Electrodiagnostic Laboratory Seward B. Rutkove, MD, FAAN
11:30 AM - 07:00 PM	Abstract	455 - Feasibility and Validation of Modified Oculobulbar Facial Respiratory Score (mOBFRS) in Amyotrophic Lateral Sclerosis Marie Wencel, CCRP
11:30 AM - 07:00 PM	Abstract	456 - A New Method to Detect Potential Causative Genes for Spastic Paraplegia Utilizing Aggregate Data of Whole Exome Sequencing Masaki Tanaka
11:30 AM - 07:00 PM	Abstract	457 - Smart Somatotopic Quantitative Sensory Testing findings in hATTR with Polyneuropathy Marcus Vinicius R. Pinto, MD
11:30 AM - 07:00 PM	Abstract	458 - Genetics in patients with hereditary neuropathy Ernesto N. Alonso-Labori, MD
11:30 AM - 07:00 PM	Abstract	459 - Correlation of supranormal sensory nerve action potential amplitudes (supraSNAPs) with sensory nerve "hyperexcitable" symptoms Philip W. Tipton, MD
11:30 AM - 07:00 PM	Abstract	460 - The Role of Needle Electromyography in the Evaluation of Carpal Tunnel Syndrome Cory J. Kogelschatz, MD
11:30 AM - 07:00 PM	Abstract	461 - Morphometry of dorsal rootlets using immunofluorescent confocal microscopy Adam Loavenbruck, MD
11:30 AM - 07:00 PM	Abstract	462 - Utility of Neuromuscular Ultrasound in the Evaluation of Proximal Median Neuropathies: A Case Series Elina Zakin, MD, FAAN
11:30 AM - 07:00 PM	Abstract	463 - Why do we repeat electrodiagnostic studies? And, does it make a difference? Shivakrishna Kovi, MD, MBBS
11:30 AM - 07:00 PM	Abstract	464 - Ultrasound Guided Open Muscle Biopsy Shumaila Sultan, MD, FAAN
11:30 AM - 07:00 PM	Abstract	465 - Clinic and Lab Based Respiratory Testing in Patients with Myasthenia Gravis Hans D. Katzberg, MD, FAAN
11:30 AM - 07:00 PM	Abstract	466 - Comparison of Train of Four with Repetitive Nerve Stimulation in the ICU Omer Suhaib, MD, MBBS
11:30 AM - 07:00 PM	Abstract	467 - Should We Refer Patients with Pain for Electromyography? Shivkumar Bhadola, MD
11:30 AM - 07:00 PM	Abstract	468 - Functional neurological disorders in Parkinson disease Benjamin Wissel
11:30 AM - 07:00 PM	Abstract	469 - Ghost in the Machine: Historical Aspects of Irreversible Brain Injury and Brain Death Yi Tong
11:30 AM - 07:00 PM	Abstract	470 - Discovery of novel recessive genes in a consanguineous cohort using genotype-phenotype correlations Kirsten Martin
11:45 AM - 11:50 AM	Discussion	P2.027
11:50 AM - 11:55 AM	Discussion	P2.028
11:55 AM - 12:00 PM	Discussion	P2.029
12:00 PM - 12:05 PM	Discussion	P2.030
12:05 PM - 12:10 PM	Discussion	P2.031
12:10 PM - 12:15 PM	Discussion	P2.032
12:15 PM - 12:20 PM	Discussion	P2.033
12:20 PM - 12:25 PM	Discussion	P2.034
12:25 PM - 12:30 PM	Discussion	P2.035
12:30 PM - 12:35 PM	Discussion	P2.036
05:30 PM - 07:00 PM	Discussion	Poster Author Standby Time

Faculty Disclosures
Salvatore DiMauro, MD	No disclosure on file
Barry D. Jordan, MD	Dr. Jordan has nothing to disclose.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Elliot M. Frohman, MD, FAAN	Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Horacio C. Kaufmann, MD, FAAN	Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
J. E. Ahlskog, MD, PhD	Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Jeremy M. Shefner, MD, PhD, FAAN	Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Karl D. Kieburtz, MD	Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
O. C. Snead III, MD, FAAN	Dr. Snead has nothing to disclose.
Vern C. Juel, MD, FAAN	Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Terry D. Fife, MD, FAAN	Dr. Fife has nothing to disclose.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN	Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Caroline M. Tanner, MD, PhD, FAAN	Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Michael K. Racke, MD	Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Stanley H. Appel, MD, FAAN	Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Katherine D. Mathews, MD, FAAN	Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
John L. Thompson, PhD	The institution of Dr. Thompson has received research support from NIH.
Safwan S. Jaradeh, MD, FAAN	Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Vladimir Hachinski, MD, DSc, FAAN	Dr. Hachinski has nothing to disclose.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Devon I. Rubin, MD, FAAN	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
David Solomon, MD, PhD	No disclosure on file
Joseph E. Parisi, MD	Dr. Parisi has nothing to disclose.
C. W. Olanow, MD	Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Basil T. Darras, MD	The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Kelly E. Lyons, PhD	Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Parkinson's Foundation. Dr. Lyons has a non-compensated relationship as a President with International Essential Tremor Foundation that is relevant to AAN interests or activities.
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Matthew P. Wicklund, MD, FAAN	Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Ted M. Dawson, MD, PhD, FAAN	Dr. Dawson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Valted Seq Inc. An immediate family member of Dr. Dawson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Valted Seq Inc. An immediate family member of Dr. Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for eNeuro. Dr. Dawson has stock in Valted Seq. Dr. Dawson has stock in American Gene Technologies International Inc. Dr. Dawson has stock in Inhibikase Therapeutics, Inc. Dr. Dawson has stock in D&D Pharmatech. Dr. Dawson has stock in Abbvie. An immediate family member of Dr. Dawson has stock in Valted Seq Inc. An immediate family member of Dr. Dawson has stock in Inhibikase Therapeutics. An immediate family member of Dr. Dawson has stock in D&D Pharmatech. The institution of Dr. Dawson has received research support from Sun Pharmaceutical Industries Ltd. The institution of Dr. Dawson has received research support from Aevum. Dr. Dawson has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dawson has received intellectual property interests from a discovery or technology relating to health care. Dr. Dawson has received personal compensation in the range of $100,000-$499,999 for serving as a Advisor with Mitokinin.
Anne H. Cross, MD, FAAN	Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Silva Markovic-Plese, MD, FAAN	Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Academy of Neurology. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Richard P. Mayeux, MD, MSc, FAAN	Dr. Mayeux has nothing to disclose.
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Mark J. Morrow, MD	No disclosure on file
Jesse M. Cedarbaum, MD, FAAN	No disclosure on file
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Ira Shoulson, MD	Dr. Shoulson has received research support from Vaccinex.
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Eric L. Logigian, MD, FAAN	Dr. Logigian has nothing to disclose.
Robert C. Griggs, MD, FAAN	Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Strongbridge Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biopharma. Dr. Griggs has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lippincott. The institution of Dr. Griggs has received research support from PTC Pharmaceuticals. The institution of Dr. Griggs has received research support from Sarepta Pharmaceuticals. The institution of Dr. Griggs has received research support from National Institutes of Health. The institution of Dr. Griggs has received research support from Santhere Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. Dr. Griggs has a non-compensated relationship as a Board of Directors;Chair Research Advisory Committee with American Brain Foundation that is relevant to AAN interests or activities.
Andrew Kertesz, MD, FAAN	No disclosure on file
Jeffrey Binder, MD	No disclosure on file
Douglas A. Kerr, MD, PhD	Dr. Kerr has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trace Neuroscience. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Spolia Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AAVantgarde Therrapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Trace Neuroscience. Dr. Kerr has or had stock in Dyne Therapeutics.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Barbara P. Karp, MD, FAAN	Dr. Karp has nothing to disclose.
Brian Crum, MD	Dr. Crum has nothing to disclose.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Julius Latorre, MD, FAAN	Dr. Latorre has nothing to disclose.
Reyna Duron, MD	No disclosure on file
Eduardo A. De Sousa, MD, FAAN	No disclosure on file
Catherine Lomen-Hoerth, MD, PhD, FAAN	Dr. Lomen-Hoerth has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Perry Shieh, MD, PhD, FAAN	Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Carlos Portera-Cailliau, MD, PhD	No disclosure on file
Lola C. Morgan, MD	Dr. Morgan has nothing to disclose.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Yoon-Hee Cha, MD, FAAN	The institution of Dr. Cha has received research support from Mal de Debarquement Balance Disorders Foundation. Dr. Cha has received research support from University of Minnesota. Dr. Cha has received research support from MNDrive.
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Rhonda Voskuhl, MD	Dr. Voskuhl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CleopatraRX. Dr. Voskuhl has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for CleopatraRX. Dr. Voskuhl has or had stock in CleopatraRX. The institution of Dr. Voskuhl has received research support from NIH. The institution of Dr. Voskuhl has received research support from Conrad N Hilton Foundation. Dr. Voskuhl has received intellectual property interests from a discovery or technology relating to health care.
Myriam Srour, MD, PhD	Dr. Srour has nothing to disclose.
Kottil W. Rammohan, MD	Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Jeffery Vance, MD, PhD	Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Vineeta Singh, MD, FAAN	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genae Americas, Inc. .
Max J. Hilz, MD, PhD, FAAN	Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Norman J. Schatz, MD	No disclosure on file
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hyperfine. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. The institution of Dr. Mechtler has received research support from Hyperfine. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Jaime R. Lopez, MD	An immediate family member of Dr. Lopez has received personal compensation for serving as an employee of AbbVie. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Lopez has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical-legal consulting.
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Nestor Galvez-Jimenez, MD	Dr. Galvez-Jimenez has nothing to disclose.
Luanne Metz, MD	The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Jeff Kraakevik, MD, FAAN	Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Leslie H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Michael Cartwright, MD	Dr. Cartwright has received publishing royalties from a publication relating to health care.
Samiya Rashid, DO	No disclosure on file
Hans D. Katzberg, MD, FAAN	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Natalia S. Rost, MD, MPH, FAAN, FAHA	Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
H. C. Diener, MD, FAAN	Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Christopher M. Filley, MD, FAAN	Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Cindy Zadikoff, MD	Dr. Zadikoff has received personal compensation for serving as an employee of AbbVie.
Jennifer M. Kwon, MD, FAAN	Dr. Kwon has nothing to disclose.
Jorge C. Kattah, MD, FAAN	Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Neelum T. Aggarwal, MD	Dr. Aggarwal has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Andrew G. Engel, MD, FAAN	The institution of Dr. Engel has received research support from NIH.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Peter Schmidt, MD	No disclosure on file
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Steven R. Hamilton, MD	No disclosure on file
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Christoph Kleinschnitz, MD	Dr. Kleinschnitz has nothing to disclose.
Carlos Singer, MD	Dr. Singer has nothing to disclose.
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Daniel Becker, MD	Dr. Becker has nothing to disclose.
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Shoji Tsuji, MD, PhD	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Osamu Onodera, MD	Dr. Onodera has nothing to disclose.
Ann Gruber-Baldini	No disclosure on file
Yi-Chung Lee, MD, FAAN	The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Mark S. LeDoux, MD, PhD	No disclosure on file
Alrabi Tawil, MD, FAAN	Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for meRicule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care.
James H. Bower, MD, MSc, FAAN	The institution of Dr. Bower has received research support from Abbvie.
Charlene R. Hoffman-Snyder, DNP	No disclosure on file
Maria M. Zak, NP	No disclosure on file
Giovanni Meola, MD, FAAN	No disclosure on file
Francois Dubeau, MD	Dr. Dubeau has nothing to disclose.
Ruggero Capra, MD	Dr. Capra has nothing to disclose.
Fen-Lei F. Chang, MD, PhD	Dr. Chang has nothing to disclose.
Lindsay A. Farrer, MD	No disclosure on file
Dong Jin Shin, MD	Dr. Shin has nothing to disclose.
Corey C. Ford, MD, PhD, FAAN	No disclosure on file
Ratna K. Bhavaraju-Sanka, MD, FAAN	Dr. Bhavaraju-Sanka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Bhavaraju-Sanka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Joe Verghese, MD, FAAN	Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
	No disclosure on file
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Angelo Ghezzi, MD	No disclosure on file
Andrea Falini	No disclosure on file
Bruno Colombo	Bruno Colombo has nothing to disclose.
Michael Gurevich	No disclosure on file
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Weihua Zhao, MD	No disclosure on file
David R. Beers, PhD	No disclosure on file
Jean-Baptiste Riviere, MSc	No disclosure on file
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Nilufer Taner, MD, PhD, FAAN	The institution of Dr. Taner has received research support from NIH.
Pablo Villoslada, MD, PhD, FAAN	Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Lawrence A. Zeidman, MD, FAAN	Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zeidman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Smith Blake Hill LLC. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.
Maria Alejandra Gonzalez Duarte, MD, FAAN	Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Gregory P. Van Stavern, MD, FAAN	Dr. Van Stavern has received publishing royalties from a publication relating to health care.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
James D. Bowen, MD	Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Noah Rosen, MD, FAAN	Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer . Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Rosen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
John R. Guy, MD	No disclosure on file
Rana K. Zabad, MD, FAAN	Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Syed F. Zaidi, MD	Dr. Zaidi has nothing to disclose.
Richard S. Nicholas, FRCP	Dr. Nicholas has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Dheeraj Khurana, MD	Dr. Khurana has nothing to disclose.
Christopher H. Gibbons, MD, FAAN	Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care.
Kallol R. Chaudhuri, MD, FRCP	Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Antonio V. Delgado-Escueta, MD	Dr. Delgado-Escueta has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Niall Tubridy, MD	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Joseph J. Higgins, MD, FAAN	No disclosure on file
Saad M. Alrajeh, MB	No disclosure on file
Mohammed A. Al-Jumah, MD, MBBS, FAAN	No disclosure on file
Laura Herbelin	No disclosure on file
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Bernhard Hemmer, MD	No disclosure on file
Koon Ho Chan, MD, MBBS	No disclosure on file
Ralitza H. Gavrilova, MD	Dr. Gavrilova has nothing to disclose.
Ayse Altintas, MD	Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Gloria Von Geldern, MD, FAAN	The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Pradeep K. Sahota, MD, FAAN	The institution of Dr. Sahota has received research support from VA Merit award.
Gyula Acsadi, MD, FAAN	Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Husam Kayyali, MD	No disclosure on file
John M. Bertoni, MD, PhD, FAAN	Dr. Bertoni has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Agnieszka Slowik, MD, FAAN	Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer, . Dr. Slowik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Payam Soltanzadeh, MD, FAAN	The institution of Dr. Soltanzadeh has received research support from Ra Pharma (UCB). The institution of Dr. Soltanzadeh has received research support from Avidity Biosciences.
Elizabeth A. Felton, MD, PhD	Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nestle Health Science. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker with American Epilepsy Society. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving as a Webinar Series Speaker with Epilepsy Foundation.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Klaus G. Madsen	No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN	Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Finn Sellebjerg, MD	Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Mustapha A. Danesi, MD	No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Peter J. Dyck, MD, FAAN	Dr. Dyck has nothing to disclose.
Teresa Frohman, PA	No disclosure on file
Hiroyuki Ishiura, MD	No disclosure on file
Jacqueline Montes, PT, EdD, NCS	Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Richard Buchsbaum	No disclosure on file
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Kameshwar Prasad, MD	The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Rohit Bhatia, MD, MBBS, DM	Dr. Bhatia has nothing to disclose.
Owen A. Ross, PhD	Dr. Ross has nothing to disclose.
Robert E. Chen, MD, MBBChir	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Maurizio Facheris, MD, MSc	Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has or had stock in Vanqua Bio.
Nabila Dahodwala, MD, FAAN	Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Minerva Carrasquillo	The institution of Minerva Carrasquillo has received research support from NIA. The institution of Minerva Carrasquillo has received research support from Carl Angus DeSantis Foundation. The institution of Minerva Carrasquillo has received research support from Florida Department of Health. Minerva Carrasquillo has received personal compensation in the range of $500-$4,999 for serving as a Reviewer for Study Section with NIH.
Xin Ming Shen, PhD, FAAN	The institution of Dr. Shen has received research support from NIH. The institution of Dr. Shen has received research support from Myasthenia Gravis Foundation of American.
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Abraham N. Lieberman, MD, FAAN	No disclosure on file
Jonathan Haines, MD	No disclosure on file
D B. Sinclair, MD	No disclosure on file
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Bruce Hermann, PhD	Bruce Hermann, PhD has nothing to disclose.
Robert G. Holloway, MD, MPH, FAAN	Dr. Holloway has nothing to disclose.
Deborah M. Miller, PhD	Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Edward J. Cupler, MD, FAAN	Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Joseph S. Jeret, MD, FAAN	No disclosure on file
Rana R. Said, MD, FAAN	Dr. Said has nothing to disclose.
Ashis H. Tayal, MD	Dr. Tayal has nothing to disclose.
Sunita Dergalust, PharmD	Ms. Dergalust has nothing to disclose.
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Melissa Armstrong, MD, MSc, FAAN	The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Brandi R. French, MD	Dr. French has nothing to disclose.
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Yoshio Tsuboi, MD	Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceutical Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sumitomo Dainippon Pharma Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie GK,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka Pharmaceutical Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin Co., Ltd.. The institution of Dr. Tsuboi has received research support from Nipro Corporation.
Angela B. Deutschlander, MD	No disclosure on file
Antonio Arauz, MD, PhD	Dr. Arauz has nothing to disclose.
Jayne Ness, MD	An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Lucas Restrepo, MD, PhD	Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Denis B. Bichuetti, MD	No disclosure on file
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Margaret A. Pericak-Vance, PhD	Dr. Pericak-Vance has nothing to disclose.
Patrick S. Reynolds, MD, FAAN	Dr. Reynolds has nothing to disclose.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Sasha Zivkovic, MD, FAAN	Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical services.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
John M. Ringman, MD, FAAN	The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Mark Obermann, MD, FAAN	No disclosure on file
Alexander Pantelyat, MD, FAAN	Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Shigeo Murayama, MD, PhD	No disclosure on file
Minhua Yang	No disclosure on file
Richard S. Finkel, MD, FAAN	Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
J. Douglas Miles, MD, PhD, FAAN	Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Neil R. Friedman, MD, MBChB	No disclosure on file
Darryl C. De Vivo, MD, FAAN	Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Marcelo C. Kremenchutzky, MD, FAAN	No disclosure on file
Kevin M. Biglan, MD	Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Bruce H. Cohen, MD, FAAN	Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abliva/NeuroVive/Pharming. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis/Zogenix/USB. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision BioSciences . Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for Pretzel. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth Bio. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Allergan. The institution of Dr. Cohen has received research support from Stealth Biotherapeutics. The institution of Dr. Cohen has received research support from BioElectron Technologies/PTC. The institution of Dr. Cohen has received research support from Astellas/MitoBridge. The institution of Dr. Cohen has received research support from Reneo Pharmaceuticals. The institution of Dr. Cohen has received research support from Abliva/Pharming. The institution of Dr. Cohen has received research support from Tisento. Dr. Cohen has received publishing royalties from a publication relating to health care. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant with US DOJ/HHS; DVIC. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a CPT Advisor with AAN. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Society that is relevant to AAN interests or activities. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Foundation that is relevant to AAN interests or activities.
Thomas O. Crawford, MD	Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Ann H. Tilton, MD, FAAN	Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date.
Jaime Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Alessandro Di Rocco, MD	Dr. Di Rocco has nothing to disclose.
Ida Y. Sarova-Pinhas, MD	No disclosure on file
Duygu Selcen, MD, FAAN	Dr. Selcen has nothing to disclose.
Chantal Poulin, MD, FRCPC	No disclosure on file
Joan M. Brengman	No disclosure on file
Dimos Dimitrios D. Mitsikostas, MD, PhD	The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Marios Hadjivassiliou	Marios Hadjivassiliou has nothing to disclose.
Nils Koch-Henriksen, MD	Dr. Koch-Henriksen has nothing to disclose.
Peter Novak, MD	Dr. Novak has received personal compensation for serving as an employee of Dysimmune Disease Foundation. Dr. Novak has stock in Pfeizer. Dr. Novak has stock in Moderna. Dr. Novak has stock in Novavax. Dr. Novak has stock in Editas Medicine. Dr. Novak has stock in Prothena. Dr. Novak has received publishing royalties from a publication relating to health care.
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Seong H. Choi, MD, PhD	No disclosure on file
Pariwat Thaisetthawatkul, MD, FAAN	Dr. Thaisetthawatkul has nothing to disclose.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Christian J. Lueck, MD, FAAN	No disclosure on file
Noel Carlson, PhD	The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Brett J. Theeler, MD, FAAN	Dr. Theeler has nothing to disclose.
Michelle Monje, MD, PhD, FAAN	An immediate family member of Dr. Monje has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for MapLight Therapeutics . An immediate family member of Dr. Monje has stock in MapLight Therapeutics .
Eduard Bercovici, MD	No disclosure on file
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Frank Bennett, PhD	No disclosure on file
Wendy Chung, MD, PhD	Wendy Chung, MD, PhD has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Prime Medicine. The institution of Wendy Chung, MD, PhD has received research support from GeneDx. The institution of Wendy Chung, MD, PhD has received research support from Illumina.
Philippe Gailloud, MD	Dr. Gailloud has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerenovus. Dr. Gailloud has received stock or an ownership interest from ArtVentive. The institution of Dr. Gailloud has received research support from Siemens Medical.
Eliza M. Gordon-Lipkin, MD	No disclosure on file
Atsushi Iwata, MD	No disclosure on file
Kensaku Kasuga	No disclosure on file
Humaira Khan, MD	Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Content creator with American Academy of Neurology Institute.
Nina Natarajan, MD	The institution of Dr. Natarajan has received research support from Biogen, INc.
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Joanna Pera, MD	No disclosure on file
Luis D. Medina, PhD	The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to AAN interests or activities.
Ju-Hong Min, MD	No disclosure on file
Anis Mir	No disclosure on file
Manish Modi, MD	Dr. Modi has nothing to disclose.
Anne C. Roc, PhD	No disclosure on file
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Anna Schubart	No disclosure on file
Audrey Strongosky	No disclosure on file
Alexis M. Taylor, MD	No disclosure on file
Marcia Waddington Cruz, MD	Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk.
Xin Zhang	No disclosure on file
Roy Alcalay, MD	Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Sheila Asghar, MD	Dr. Asghar has nothing to disclose.
Shay Menascu, MD	No disclosure on file
Michael W. Devereaux, MD, FAAN	Dr. Devereaux has received personal compensation for serving as an employee of DigiTrace part of Sleepmed. Dr. Devereaux has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kevin Trangle and Associates.
Duarte G. Machado, MD, FAAN	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Paul T. Twydell, DO, FAAN	Dr. Twydell has received publishing royalties from a publication relating to health care.
Jennifer J. Manly, PhD	The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
Joung-Ho Rha, MD, PhD	No disclosure on file
Xiomara Q. Rosales, MD	No disclosure on file
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Joseph M. Ferrara, MD, FAAN	No disclosure on file
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Florian Deisenhammer, MD	Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Deisenhammer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SOBI.
Craig McDonald, MD	Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Sumit Parikh, MD	Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care.
Brandon R. Barton, MD, FAAN	Dr. Barton has nothing to disclose.
Brent P. Goodman, MD	Dr. Goodman has nothing to disclose.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Nicole Schupf, PhD, DrPH	No disclosure on file
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Nazem Atassi, MD	Dr. Atassi has received personal compensation for serving as an employee of Sanofi. Dr. Atassi has stock in Sanofi.
Russell P. Saneto, DO, PhD	Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REATA. Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Pharmaceuticals. The institution of Dr. Saneto has received research support from NIH. The institution of Dr. Saneto has received research support from Zogenix. The institution of Dr. Saneto has received research support from GW Pharmaceuticals.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Gustavo A. Suarez-Zambrano, MD	Dr. Suarez-Zambrano has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America.
Christiane Reitz, MD, PhD	No disclosure on file
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Sarlota Mesaros	Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Hemofarm. Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Jun Mitsui	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Filippo Martinelli Boneschi	No disclosure on file
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Yoshimi Sogawa, MD	Dr. Sogawa has nothing to disclose.
Danish Bhatti, MD, FAAN	Dr. Bhatti has nothing to disclose.
Federica Esposito	Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Robert Laforce, Jr., MD, PhD	Dr. Laforce has nothing to disclose.
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Weining Robieson, PhD	Dr. Robieson has received personal compensation for serving as an employee of AbbVie. Dr. Robieson has received stock or an ownership interest from AbbVie.
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Niall Pender, PhD	No disclosure on file
Sharmilee Gnanapavan, MB	Dr. Gnanapavan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Gnanapavan has received research support from NIHR.
Michael G. Harrington, MD	No disclosure on file
Araya Puwanant, MD	The institution of Dr. Puwanant has received research support from NIH/NINDS.
Jose Gutierrez, MD	Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Tanja D. Kuhlmann, MD	No disclosure on file
Letizia M. Leocani, MD	Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Daniel Weintraub	Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Hassan Fathallah-Shaykh, MD	No disclosure on file
Reem F. Bunyan, MD	No disclosure on file
Belen Pascual, PhD	The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Nadir A. Syed, MD	No disclosure on file
Chad Hoyle, MD	Dr. Hoyle has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for National Football League. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Hoyle has received research support from REATA. The institution of Dr. Hoyle has received research support from TAKEDA.
Michael Hecker, PhD	No disclosure on file
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Connie C. Marras, MD	Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Judith Bellmann-Strobl, MD	Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
R. Michael Gendreau	No disclosure on file
David Collas, MD	No disclosure on file
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN	Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wellcome Trust. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from Rosetrees Trust. The institution of Dr. De Luca has received research support from Strategic Innovation Fund, Oxford University. The institution of Dr. De Luca has received research support from Agence National de la Recherche. Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Continuum (AAN) that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Frontiers in Neurology that is relevant to AAN interests or activities.
Stephanie P. Dubow, DO	No disclosure on file
Bruce D. Trapp, PhD	Dr. Trapp has received personal compensation for serving as an employee of Renovo Neural Inc.. The institution of Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therini Bio, Inc.. Dr. Trapp has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Trapp has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm Therapeutics. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kantonsspital Aarau AG. Dr. Trapp has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for triMS.online. The institution of Dr. Trapp has received research support from Genzyme Corporation. The institution of Dr. Trapp has received research support from ALS Association. The institution of Dr. Trapp has received research support from National Institute of Neurological Disorders and Stroke.
Arsalan Ahmad, MD	Dr. Ahmad has received stock or an ownership interest from Shifa International Hospitals Limited (Current employer).
Mhd R. Alkawadri, MD	Dr. Alkawadri has nothing to disclose.
Miya Asato, MD, FAAN	Dr. Asato has nothing to disclose.
Antoaneta J. Balabanov, MD	Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen.
Sat Dev Batish, PhD, FAAN	Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Peter Bede, MD, PhD	Dr. Bede has nothing to disclose.
Gary W. Beecham, PhD	The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
Danny Bega, MD	Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SOM. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
Simona Bonavita	No disclosure on file
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Shawna M. Cutting, MD, FAAN	The institution of Dr. Cutting has received research support from Genentech.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Educational Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Marc Dinkin, MD	Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bush Graziano Rice & Platter, P.A.. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, PC.
Elizabeth Donner, MD, FRCPC	Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR.
Sally Dunaway, DPT	Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Mark R. Etherton, MD	Dr. Etherton has received personal compensation for serving as an employee of Takeda Pharmaceutical Company. Dr. Etherton has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Argenica Therapeutics.
Namita Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
June Halper, RN, ANP	Ms. Halper has nothing to disclose.
Ji Hoe Heo, MD, PhD	No disclosure on file
Hong Jiang, MD, PhD	The institution of Dr. Jiang has received research support from Florida Health. The institution of Dr. Jiang has received research support from NINDS RO1.
Julie A. Khoury, MD	Dr. Khoury has nothing to disclose.
Doris Kung, DO, FAAN	Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Jin Li, MD, PhD, FAAN	Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with AAN that is relevant to AAN interests or activities.
Teerin Liewluck, MD, FAAN	Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Maria Lukasik, MD, PhD	No disclosure on file
Caterina Mainero, MD, PhD	The institution of Dr. Mainero has received research support from Genentech.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Sarah A. Morrow, MD, MSC, FRCPC, FAAN	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Hyo Suk Nam	No disclosure on file
Babak Navi, MD	Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Annette Bang Oturai, MD	Dr. Oturai has nothing to disclose.
Sandipan Pati, MD	Dr. Pati has nothing to disclose.
Sindhu Ramchandren, MD	Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson.
Randal Richardson, MD	No disclosure on file
Matthew S. Robbins, MD, FAAN	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, American Academy of Neurology that is relevant to AAN interests or activities.
Rehan Sajjad, MD	No disclosure on file
Nirav Sanghani, MBBS	Dr. Sanghani has nothing to disclose.
Stephen Sawcer, PhD	No disclosure on file
Alessandro Serra, MD	Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Stephanie Syc-Mazurek, MD, PhD	Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Charles A. Szabo, MD, FAAN	Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Deepti Vibha, MD	Dr. Vibha has nothing to disclose.
Mary A. Willis, MD, FAAN	Dr. Willis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb.
Allison Wright Willis, MD	Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Carolina Barnett Tapia, MD	Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Amitava Chakrabarti, MD, MBBS	No disclosure on file
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Jessica Robinson Papp, MD, FAAN	Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immgenuity Inc. Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropathix Inc. The institution of Dr. Robinson Papp has received research support from NIH. Dr. Robinson Papp has received publishing royalties from a publication relating to health care.
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Elizabeth Finger, MD, FAAN	Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with American Academy of Neurology.
Marco T. Medina, MD, FAAN	Dr. Medina has nothing to disclose.
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Jose Avila-Ornelas, MD	Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Banner Pharmaceuticals.
Orlando G. Barsottini, MD, PhD	Dr. Barsottini has nothing to disclose.
Alexander U. Brandt, MD	No disclosure on file
Diana Castro, MD	Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Castro has received research support from Biogen. The institution of Dr. Castro has received research support from Sarepta. The institution of Dr. Castro has received research support from Fibrogen .
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Kathrin LaFaver, MD, FAAN	Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to AAN interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to AAN interests or activities.
Feza Deymeer, MD	No disclosure on file
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Mohammed A. ElSherif, MD, PhD, FAAN	Dr. ElSherif has nothing to disclose.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Ajay Garg	Ajay Garg has nothing to disclose.
Allan M. Glanzman, PT	Mr. Glanzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Mr. Glanzman has received intellectual property interests from a discovery or technology relating to health care.
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Maria del Pilar Guillermo Prieto Eibl, MD	Dr. Guillermo Prieto Eibl has nothing to disclose.
Kymberly Gyure, MD	No disclosure on file
Dagny N. Holle, MD	Dr. Holle has nothing to disclose.
Takeshi Ikeuchi, MD	Dr. Ikeuchi has nothing to disclose.
Parameswaran M. Iyer, Jr., MD, MBBS	No disclosure on file
Imad T. Jarjour, MD, FAAN	No disclosure on file
Laila K. Jarjour, MB ChB MPH	No disclosure on file
Beomseok Jeon, MD	Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Thomas Korn	No disclosure on file
Tobias B. Kulik, MD, FAAN	Dr. Kulik has nothing to disclose.
Abhay Kumar, MD	Dr. Kumar has nothing to disclose.
Codrin I. Lungu, MD, FAAN	Dr. Lungu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, inc..
Rama K. Maganti, MD, FAAN	No disclosure on file
Charles Maitland	No disclosure on file
Soe S. Mar, MD, FAAN	The institution of Dr. Mar has received research support from NIH.
Iris E. Martinez-Juarez, MD	No disclosure on file
Daniel Martinez-Ramirez, MD	Dr. Martinez-Ramirez has nothing to disclose.
Henry P. Moore, MD	Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Francesco Muntoni, MD	Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Steffen Naegel, MD	No disclosure on file
Viet Nguyen, MD	Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Hiroaki Nozaki, MD, PhD	No disclosure on file
Dimitrios Papadopoulos, MD	No disclosure on file
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Stephane Poulin, MD	No disclosure on file
Sandra P. Reyna, MD	Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies.
Liana Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Pharmaceuticals. Dr. Rosenthal has received research support from NIH. Dr. Rosenthal has received research support from Gordon and Marilyn Macklin Foundation. Dr. Rosenthal has received research support from The Daniel B. and Florence E. Green Foundation. Dr. Rosenthal has received research support from National Ataxia Foundation. Dr. Rosenthal has received research support from Michael J. Fox Foundation. Dr. Rosenthal has received research support from Pfizer. Dr. Rosenthal has received research support from Biohaven Pharmaceuticals. Dr. Rosenthal has a non-compensated relationship as a Medical Director, ex-officio Member of the Board with National Ataxia Foundation that is relevant to AAN interests or activities.
Tatjana Rundek, MD, PhD	The institution of Dr. Rundek has received research support from NIH.
Shiv Saidha, MD	Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Naganand Sripathi, MD	Dr. Sripathi has nothing to disclose.
Shumaila Sultan, MD, FAAN	Dr. Sultan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
Shahamat Tauhid, MD	Dr. Tauhid has nothing to disclose.
Louis Verret, MD	No disclosure on file
Shelly K. Weiss, MD	No disclosure on file
Martin Weygandt, PhD	No disclosure on file
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Pavle Repovic, MD, PhD	Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Repovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Repovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyersSquibb. Dr. Repovic has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Repovic has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG therapeutics. The institution of Dr. Repovic has received research support from Genentech. The institution of Dr. Repovic has received research support from Biogen.
Angel R. Chinea, MD	Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for novartis. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan.
Ton J. DeGrauw, MD	No disclosure on file
Arun Asha Kalra, MD, FAAN	No disclosure on file
Julie A. Parsons, MD	Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
David Leppert, MD	Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Hiroshi Takashima, MD, PhD	Dr. Takashima has nothing to disclose.
Joseph M. Savitt, MD, PhD	The institution of Dr. Savitt has received research support from Bial. The institution of Dr. Savitt has received research support from UCB.
Betul B. Gundogdu, MD	Dr. Gundogdu has nothing to disclose.
Craig G. Campbell, MD	Dr. Campbell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Campbell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid. The institution of Dr. Campbell has received research support from Biogen. The institution of Dr. Campbell has received research support from Genzyme. The institution of Dr. Campbell has received research support from Acceleron, AMO, Biogen, Sarepta, Wave, PTC, Pfizer, Roche.
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Radoslaw Kazmierski, MD, PhD	Dr. Kazmierski has nothing to disclose.
Michael J. Howell, MD, FAAN	The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care.
Carlos Cosentino, MD, FAAN	Dr. Cosentino has nothing to disclose.
Enedina Oliveira, MD	No disclosure on file
Bradford B. Thompson, MD	Dr. Thompson has nothing to disclose.
Claudio Gobbi, MD	Dr. Gobbi has nothing to disclose.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Linda C. Wendell, MD, FAAN	Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Erik V. Burton, MD	Dr. Burton has nothing to disclose.
Katharina M. Busl, MD, MS, FAAN	Dr. Busl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rissman Law. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huffman Powell Baley. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University Science. Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCCM. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Assistant Editor with Neurocritical Care that is relevant to AAN interests or activities.
Kessarin Panichpisal, MD	No disclosure on file
Mario Habek, MD	Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Channa Kolb, MD	No disclosure on file
Peiqing Qian, MD	Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Anthony Feinstein, MD	Anthony Feinstein, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis, Biogen, Roche and Sanofi-Genzyme. The institution of Anthony Feinstein, MD has received research support from Multiple Sclerosis Society of Canada. Anthony Feinstein, MD has received publishing royalties from a publication relating to health care.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Christopher Hemond, MD	The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Mitchell G. Miglis, MD, FAAN	Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alight Health. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. The institution of Dr. Miglis has received research support from Dysautonomia International. The institution of Dr. Miglis has received research support from National Institute of Health. Dr. Miglis has received publishing royalties from a publication relating to health care.
Devin D. Mackay, MD, FAAN	Dr. Mackay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Optum. Dr. Mackay has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms.
Mario R. Cornejo Olivas, MD	Dr. Cornejo Olivas has received research support from UNIVERSIDAD CIENTIFICA DEL SUR. The institution of Dr. Cornejo Olivas has received research support from CHDI. The institution of Dr. Cornejo Olivas has received research support from NIH. The institution of Dr. Cornejo Olivas has received research support from GP2/ASAP/MJFF. Dr. Cornejo Olivas has a non-compensated relationship as a Secretary elect with MDS-PAS that is relevant to AAN interests or activities.
James R. Bateman III, MD, FAAN	Dr. Bateman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView CME. Dr. Bateman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EfficientCME. The institution of Dr. Bateman has received research support from NIA. The institution of Dr. Bateman has received research support from Dementia Alliance of North Carolina. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Drug Discovery Foundation. Dr. Bateman has a non-compensated relationship as a Committee Member with UCNS that is relevant to AAN interests or activities.
Laura Guilhoto, MD	No disclosure on file
Sumit Verma, MD	Dr. Verma has nothing to disclose.
Melanie Glenn, MD	No disclosure on file
Jonathan K. Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for OBT Law. Dr. Smith has a non-compensated relationship as a Committee Member, Clinical Neurophysiology CMOC Pilot, with ABPN that is relevant to AAN interests or activities.
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Katy Eichinger, PhD, PT, DPT, NCS	Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TRiNDS. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. The institution of Dr. Eichinger has received research support from Muscular Dystrophy Association. Dr. Eichinger has received intellectual property interests from a discovery or technology relating to health care.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Khalid S. Alqadi, MD	No disclosure on file
Klemens Ruprecht, MD	Dr. Ruprecht has received research support from European Union (821283-2). Dr. Ruprecht has received research support from Merck Serono. Dr. Ruprecht has received research support from Stiftung Charite. Dr. Ruprecht has received research support from Arthur Arnstein Foundation. Dr. Ruprecht has received publishing royalties from a publication relating to health care.
Maureen A. Mealy, PhD, RN	No disclosure on file
I-Hui Lee, MD, PhD	Dr. Lee has nothing to disclose.
Kavit Shah, MD	Dr. Shah has nothing to disclose.
Ammar Ahmed, MBBS, PhD, FRCP, Lond	No disclosure on file
Kathie M. Bishop, PhD	Dr. Bishop has received personal compensation for serving as an employee of Acadia Pharmaceuticals, Inc. . Dr. Bishop has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for DTx Pharma. Dr. Bishop has stock in Acadia Pharmaceuticals, Inc..
Jelena Drulovic	Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PharmaSwiss. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck . Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actavis TEVA. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hemofarm. Jelena Drulovic has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medis. Jelena Drulovic has received research support from Ministry of Science, Technological Development and Innovations of the Republic of Serbia.
Irena Dujmovic Basuroski, MD, PhD	The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation.
Valentina Emmanuele, MD, PhD	Dr. Emmanuele has nothing to disclose.
Chris Hackett, MA	Mr. Hackett has nothing to disclose.
Lana Harder, PhD	Dr. Harder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals.
Izabela Karbassi	No disclosure on file
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Chun-Jen Lin	No disclosure on file
Afraa M. Musa	No disclosure on file
Timm Oberwahrenbrock, PhD	No disclosure on file
Sabrina Paganoni, MD, PhD	Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Francesca Sangalli	No disclosure on file
Melih Tutuncu, MD	No disclosure on file
Patrice Whitehead	No disclosure on file
Noriko Itoh, MS	Ms. Itoh has nothing to disclose.
Jose G. Merino, MD, MPhil, FAHA, FAAN	The institution of Dr. Merino has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Merino has received personal compensation in the range of $500-$4,999 for serving as a StrokeNet DSMB Member with National Institute of Neurological Disorders and Stroke.
Adam Loavenbruck, MD	Dr. Loavenbruck has nothing to disclose.
Cristiano Oliveira, MD	Dr. Oliveira has nothing to disclose.
Robert Fishman, MD	Dr. Fishman has nothing to disclose.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Yujie Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS.
David G. Wright, MD	Dr. Wright has nothing to disclose.
Lan Qin, MD, PhD, FAAN	No disclosure on file
Daniel B. Simmons, MD	No disclosure on file
Agnes Kowalska, MD	Dr. Kowalska has nothing to disclose.
Susanta Bandyopadhyay, MD, PhD	No disclosure on file
Said R. Beydoun, MD, FAAN	Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
Pradeep C. Bollu, MD	Dr. Bollu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Leah R. Hanson, PhD	The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
Kelly Baldwin, MD	Dr. Baldwin has nothing to disclose.
Amanda L. Witt, MD	No disclosure on file
Tuhin Virmani, MD, PhD, FAAN	The institution of Dr. Virmani has received research support from Parkinson's Foundation.
Kyle Kern, MD, MS	Dr. Kern has nothing to disclose.
Anila Thomas, MD	Dr. Thomas has nothing to disclose.
Punit Agrawal, DO	No disclosure on file
Hee-Kwon Park, MD	No disclosure on file
Melinda Magyari, MD	Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Michael J. Crimmins, MD	No disclosure on file
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
James Cleland, MD	No disclosure on file
Bonnie M. Keung, MD	No disclosure on file
Ramses Ribot, MD	No disclosure on file
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Fernando Scaglia, MD	Dr. Scaglia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Francisco Javier Olascoaga Urtaza, MD	No disclosure on file
Pilar Mazzetti Soler, MD	No disclosure on file
Adam Quick, MD	The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Karen A. O'Connell, PhD	Dr. O'Connell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Matthew Imperioli, MD	Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx Pharmaceuticals . Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law offices of Scott Doody.
Jorge Zamudio, MD, MBA	Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received stock or an ownership interest from Abbvie .
Benecia Hong-Goka, MD	No disclosure on file
Peter T. Schmidt, PhD	No disclosure on file
Gishlaine Alfonso, MD, FAAN	Dr. Alfonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion .
Matthew J. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Kyowa Kirin. The institution of Dr. Barrett has received research support from NIH.
Claribel D. Wee, MD	Dr. Wee has nothing to disclose.
Mered Parnes, MD	Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Vishal Jani, MD	Dr. Jani has nothing to disclose.
Mayela D. Rodriguez Violante, MD	Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rodriguez Violante has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sandoz Novartis. Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zydus. The institution of Dr. Rodriguez Violante has received research support from LARGE-PD.
Rocio Hernandez Clares, MD, PhD	No disclosure on file
Aakash N. Bodhit, MD	No disclosure on file
Adriana Hernandez	No disclosure on file
Ashraf Zaher	No disclosure on file
Brianne Bettcher	No disclosure on file
Eun Bin Cho, MD	No disclosure on file
Faisal A. Alsallom, MD	Dr. Alsallom has nothing to disclose.
Ivan Adamec	Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jadran Galenski laboratorij. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Phoenix farmacija.
Jesper Hagemeier	No disclosure on file
Magdalena Krbot Skoric	Magdalena Krbot Skoric has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Philipp Albrecht, PhD	Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Rana Hanna AL-Shaikh, MD	Dr. Hanna AL-Shaikh has nothing to disclose.
Roopali Ghandi	No disclosure on file
Sagari R. Bette, MD	Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus.
Sanish Sathyan, PhD	No disclosure on file
Wildon Farwell, MD	Dr. Farwell has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Farwell has received personal compensation for serving as an employee of Satellos Biosciences. Dr. Farwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Paragon Therapeutics. Dr. Farwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Farwell has or had stock in Dyne Therapeutics.Dr. Farwell has or had stock in Satellos Bioscience.
Janet Benesh, BSMT	No disclosure on file
Marissa C. Natelson Love, MD, FAAN	Dr. Natelson Love has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium Pharma. Dr. Natelson Love has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Natelson Love has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burns, Cunningham & Mackey. The institution of Dr. Natelson Love has received research support from Eisai. The institution of Dr. Natelson Love has received research support from Eli Lilly. The institution of Dr. Natelson Love has received research support from Janssen. The institution of Dr. Natelson Love has received research support from Vaccinex. The institution of Dr. Natelson Love has received research support from Ono Pharmaceuticals.
Jori Fleisher, MD, MSCE, FAAN	The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Tapan R. Kavi, MD	No disclosure on file
Mark M. Stecker, MD, FAAN	No disclosure on file
Rajarshi Mazumder, MD, MPH	Dr. Mazumder has nothing to disclose.
Orhan H. Akman, PhD	No disclosure on file
Melissa L. Rayhill, MD, FAAN	Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Headache Cooperative of New England. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Clusterbusters. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with American Academy of Neurology.
Takuya Konno, MD, PhD	No disclosure on file
Jacquelyne Kane, MD	No disclosure on file
Vivek Prabhakaran, MD	Dr. Prabhakaran has nothing to disclose.
Amre Nouh, MD, FAAN	Dr. Nouh has stock in Openwater.
Sarah E. Nelson, MD, MPH, FAAN	Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journal. Dr. Nelson has received publishing royalties from a publication relating to health care. Dr. Nelson has a non-compensated relationship as a Women Leading in Neurology Program with American Academy of Neurology that is relevant to AAN interests or activities.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Saunder Bernes, MD	Dr. Bernes has nothing to disclose.
Anteneh M. Feyissa, MD, MSc, FAAN	Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Joachim Havla, MD	Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Havla has received research support from Merck.
Manoj Raghavan, MD, PhD	Dr. Raghavan has nothing to disclose.
Jacob L. McCauley	No disclosure on file
Zaza Katsarava, MD	Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Christine Holmstedt, DO	The institution of Dr. Holmstedt has received research support from NIH. The institution of Dr. Holmstedt has received research support from Patient-Centered Outcomes Research Institute.
Lan Tan	No disclosure on file
Ehtesham Khalid, MBBS	Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Krai Chatamra, PhD	No disclosure on file
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with American Academy of Neurology.
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Teddy S. Youn, MD	Dr. Youn has nothing to disclose.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
Pravin Khemani, MD, FAAN	Dr. Khemani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Trio. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Sandeep S. Rana, MD, FAAN	Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Kate Daniello, MD, FAAN	Dr. Daniello has nothing to disclose.
Rebecca C. Burch, MD	An immediate family member of Dr. Burch has received personal compensation for serving as an employee of Wellsky. Dr. Burch has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. An immediate family member of Dr. Burch has stock in Wellsky. Dr. Burch has received publishing royalties from a publication relating to health care.
Chirantan Banerjee, MD, MPH	Dr. Banerjee has nothing to disclose.
Isaac E. Silverman, MD	Dr. Silverman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms.
Octavian V. Lie, MD	No disclosure on file
Alexander M. Papanastassiou	Alexander M. Papanastassiou has received intellectual property interests from a discovery or technology relating to health care.
Laurice T. Yang, MD, MHA, FAAN	The institution of Dr. Yang has received research support from Alzheimer's Disease Research Center (ADRC). The institution of Dr. Yang has received research support from Pacific Northwest Udall Center . The institution of Dr. Yang has received research support from Biogen/Parkinson's Study Group . The institution of Dr. Yang has received research support from Eli Lily . The institution of Dr. Yang has received research support from Michael J. Fox Foundation For Parkinson's Research . The institution of Dr. Yang has received research support from Sanofi . Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Chair, Workgroup with American Academy of Neurology .
Rachel Nolan	Ms. Nolan has nothing to disclose.
Scheherazade Le, MD	Dr. Le has nothing to disclose.
Chandrashekhar Agrawal, MD	No disclosure on file
Eduardo R. Davidovich	Dr. Davidovich has nothing to disclose.
Jin-Tai Yu	No disclosure on file
Veena A. Nair, PhD	The institution of Dr. Nair has received research support from NIH.
Maria I. Reyes-Mantilla, MD	Dr. Reyes-Mantilla has nothing to disclose.
Emanuele Barca, MD, PhD	Dr. Barca has nothing to disclose.
Gabriella Garcia	No disclosure on file
Jamie Greenfield	No disclosure on file
Sheffali Gulati, MD, FAMS, FIAP, FNASc, FIANs	Prof. Gulati has nothing to disclose.
Dieter Haering	Dieter Haering has received personal compensation for serving as an employee of Novartis.
Janace Hart	No disclosure on file
Haris Kamal, MD	Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Tatsuo Mano, MD, PhD	No disclosure on file
Navid Manouchehri, MD	Navid Manouchehri has nothing to disclose.
Maria Antonietta Mazzola, MD	Dr. Mazzola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec.
Michelle M. Mielke, PhD	Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Allison P. Navis, MD	The institution of Dr. Navis has received research support from NIH Loan Repayment Program.
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
Melissa Sorosina	Melissa Sorosina has received research support from Italian Multiple Sclerosis Foundation. Melissa Sorosina has received research support from Italian Ministry of Health.
Aravindhan Veerapandiyan, MD	Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Klemens Winder, MD	No disclosure on file
David E. Jones, MD, FAAN	Dr. Jones has received personal compensation for serving as an employee of Genentech. Dr. Jones has stock in Roche.
Veronica E. Santini, MD, MA, FAAN	Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion NeuroStim, Inc. The institution of Dr. Santini has received research support from MeiraGTx, LLC. The institution of Dr. Santini has received research support from Ono Pharmaceuticals. The institution of Dr. Santini has received research support from Lundbeck. The institution of Dr. Santini has received research support from American Parkinson Disease Association. The institution of Dr. Santini has received research support from Mission MSA. The institution of Dr. Santini has received research support from CurePSP. The institution of Dr. Santini has received research support from Parkinson Foundation. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with American Academy of Neurology. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with International Parkinson and Movement Disorders Society. Dr. Santini has received personal compensation in the range of $0-$499 for serving as a invited speaker with Parkinson Study Group. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a data safety monitoring board with NIH.
Glen A. Cook, Jr., MD, FAAN	Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma.
Carmen Serrano, MD, FAAN	The institution of Dr. Serrano has received research support from Eli Lilly. The institution of Dr. Serrano has received research support from Abbvie.
Eugene May, MD, FAAN	No disclosure on file
Kameel Karkar, MD	No disclosure on file
James T. Boyd, MD	Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroDerm . Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InTrance. Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson Study Group . The institution of Dr. Boyd has received research support from NIA/NIH. The institution of Dr. Boyd has received research support from Biotie . The institution of Dr. Boyd has received research support from vaccinex. The institution of Dr. Boyd has received research support from CHDI. The institution of Dr. Boyd has received research support from AbbVie. The institution of Dr. Boyd has received research support from Roche . The institution of Dr. Boyd has received research support from Revance . The institution of Dr. Boyd has received research support from NeuroDerm. The institution of Dr. Boyd has received research support from Neurocrine .
Daniel Goldenholz, MD, PhD	Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuro Event Labs. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for IDR. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova . Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Advances . Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AAN. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACNS. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AES. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nebraska Neurological Society . The institution of Dr. Goldenholz has received research support from NIH. The institution of Dr. Goldenholz has received research support from BIDMC. Dr. Goldenholz has a non-compensated relationship as a advisor with Eysz that is relevant to AAN interests or activities. Dr. Goldenholz has a non-compensated relationship as a advisor with Epilepsy AI that is relevant to AAN interests or activities.
Eman M. Nassim Ali, MD	Dr. Nassim Ali has nothing to disclose.
Jameela A. Saeedi, MD	No disclosure on file
Adel Alhazzani, MD, FRCPC, FAAN	Dr. Alhazzani has nothing to disclose.
Sarah R. Risen, MD	Dr. Risen has nothing to disclose.
Victor H. Gonzalez-Montoya, MD	No disclosure on file
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Meredith C. Frederick, MD	No disclosure on file
Yasaman Kianirad, MD	Dr. Kianirad has nothing to disclose.
Chindo B. Mallum, MD	Dr. Mallum has nothing to disclose.
Jessica Wilcox, MD	Dr. Wilcox has nothing to disclose.
Dylan Alegria, MD, MS	No disclosure on file
Riadh Gouider, MD, FAAN	Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Davorka Tomic	Davorka Tomic has stock in Meck KGaA.
Eva Costa Arpin, MD	No disclosure on file
Joel N. Phillips, DO, FAAN	Dr. Phillips has nothing to disclose.
Zabeen K. Mahuwala, MD, FAAN	Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Scientific affairs. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Brittani L. Conway, MD	Dr. Conway has nothing to disclose.
Janet Elgallab, MD	No disclosure on file
Kara L. Steijlen, MD	Dr. Steijlen has nothing to disclose.
Manan Shah, MD, MBBS	Dr. Shah has nothing to disclose.
Thananan Thammongkolchai, MD	No disclosure on file
Natalie L. McClure, PhD	No disclosure on file
Zhenyuan Wang, PhD	Dr. Wang has nothing to disclose.
Adeel A. Memon, MD	The institution of Dr. Memon has received research support from NIH/NINDS.
Matthew J. Burke, MD, FRCPC	Dr. Burke has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Burn Tucker Lachaîne. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Lerners LLP. Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Blakes LLP. Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Carroll Heyd Chown LLP. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Caza Saikaley LLP. The institution of Dr. Burke has received research support from Liu Fu Yu Charity Foundation.
Omar M. Hussein, MD	No disclosure on file
Sharon Chiang, MD, PhD	Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Badri Vardarajan	Badri Vardarajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kodikaz Therapeutics.
Catherine Kopil	No disclosure on file
Cindy Yoon	No disclosure on file
Claire Modica	An immediate family member of Claire Modica has received personal compensation for serving as an employee of Thermo Fisher Scientific. The institution of Claire Modica has received research support from Congressionally Directed Medical Research Programs. The institution of Claire Modica has received research support from Office of Naval Research.
Ermelinda De Meo	Ms. De Meo has nothing to disclose.
Antonio Gallo	Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Gloria Dalla Costa	No disclosure on file
Hung-Ming Wu	No disclosure on file
Janina Behrens	No disclosure on file
Jing Wang, MD	No disclosure on file
Jose Luiz Pedroso, MD	Dr. Pedroso has nothing to disclose.
Luigi Lavorgna	Luigi Lavorgna has nothing to disclose.
Michelle R. Caunca, MD, PhD	Ms. Caunca has nothing to disclose.
Muhammad Ahmed, MD	Dr. Ahmed has nothing to disclose.
Nicholas Thompson	The institution of Nicholas Thompson has received research support from EMD Serono.
Pirouz Piran, MD	No disclosure on file
Samden Lhatoo, MD	Dr. Lhatoo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LivaNova. The institution of Dr. Lhatoo has received research support from NIH. Dr. Lhatoo has received intellectual property interests from a discovery or technology relating to health care. Dr. Lhatoo has received publishing royalties from a publication relating to health care.
Sonam Verma, MD	No disclosure on file
Takayoshi Tokutake	No disclosure on file
Ugur Sener, MD	Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Wan-Yu Huang	No disclosure on file
Wojciech Kozubski	No disclosure on file
Ana Rodriguez Regal	Ana Rodriguez Regal has nothing to disclose.
Amanda B. Weber, DO	Dr. Weber has nothing to disclose.
Drew S. Kern, MD, FAAN	Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Leighton Mohl, MD	Dr. Mohl has nothing to disclose.
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Benjamin Turner, MD, MBBS	No disclosure on file
Yan Zhang, MD	No disclosure on file
Thomas S. Wingo, MD	Dr. Wingo has nothing to disclose.
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Russell Butterfield, MD, PhD, BS	Dr. Butterfield has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Butterfield has received research support from NIH. The institution of Dr. Butterfield has received research support from Ionis. The institution of Dr. Butterfield has received research support from CDC.
Javier Gonzalez, MD	No disclosure on file
Kwan Ng, MD, PhD	Dr. Ng has nothing to disclose.
Elizabeth M. Wells, MD	The institution of Dr. Wells has received research support from National Institute of Allergy and Infectious Diseases.
Susan Shin, MD	Dr. Shin has nothing to disclose.
Brian Ahuja, MD	No disclosure on file
Carmen Castrillo-Viguera	Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Lori Mayer, RN, DNP, MSN, MSCN	Ms. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen, Genentech, Novartis, Alexion, Celgene. Ms. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentech, Novartis, Alexion, Celgene. Ms. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Genentech, Novartis, Alexion, Celgene. Ms. Mayer has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers.
Adedunni W. Olusanya, MD	No disclosure on file
Chrstoph Lassek	No disclosure on file
Chih-Wei Tang, MD	No disclosure on file
Y-Nhy Duong	No disclosure on file
Cory J. Kogelschatz, MD	No disclosure on file
Duaa Jabari, MD	Dr. Jabari has nothing to disclose.
F. Rainer Von Coelln, MD	The institution of Dr. Von Coelln has received research support from University of Maryland and Maryland State Goverment. Dr. Von Coelln has received intellectual property interests from a discovery or technology relating to health care.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Michael Reznik, MD	Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Annie S. Daniel, MBBS	Dr. Daniel has nothing to disclose.
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Justin V. Abraham, MD	Dr. Abraham has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceutical.
Asaff Harel, MD	Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Elizabeth Ackermann, PhD	No disclosure on file
Kedar Mahajan, MD, PhD	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Mahajan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Mitra Afshari, MD	Dr. Afshari has received research support from Consolidated Anti-Aging Foundation . Dr. Afshari has received research support from Parkinson Study Group.
Alirexa Faridar, MD	Dr. Faridar has nothing to disclose.
Evdokia Eleftheriou, MD	No disclosure on file
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Mohsen Pirastehfar, MD	No disclosure on file
Deepak K. Gupta, MBBS	The institution of Dr. Gupta has received research support from Department of Defense.
Nuala McNicholas, MBBS	Dr. McNicholas has nothing to disclose.
Kaye E. Sedarsky, MD	Dr. Sedarsky has nothing to disclose.
Ashutosh Kumar, MD	Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Academy of Pediatrics. The institution of Dr. Kumar has received research support from PTC therapeutics. The institution of Dr. Kumar has received research support from Sarepta Therapeutics. The institution of Dr. Kumar has received research support from Novartis/Avexis. The institution of Dr. Kumar has received research support from Fibrogen . The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Genentech. The institution of Dr. Kumar has received research support from MDA. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Draft Report Reviewer/consultant with ECRI/Atheneum/QTC commercial services LLC/Connected Research and consulting/Vox.Bio.
Sarah A. O'Shea, MD	Dr. O'Shea has nothing to disclose.
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from American Academy of Neurology.
Padma V. Hadakasira, MD	Dr. Hadakasira has nothing to disclose.
Fernando Cubillos	Mr. Cubillos has nothing to disclose.
Camilo Diaz-Cruz, MD	Dr. Diaz-Cruz has nothing to disclose.
Omer Suhaib, MD, MBBS	No disclosure on file
Ilena George, MD	The institution of Dr. George has received research support from Biogen.
Sara LaHue, MD	The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Longevity Impetus Grants. Dr. LaHue has received publishing royalties from a publication relating to health care.
Yogesh Gujrati, MD	No disclosure on file
Lisseth E. Burbano, MD, PhD	Ms. Burbano has received research support from The American Academy of Neurology.
Yolanda Reyes-Iglesias, MD, FAAN	Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Member Neuroscience Test Development Material Committee with National Board medical examiners (NBME). Dr. Reyes-Iglesias has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Harvard Prime Med Series.
Lisena Hasanaj	Ms. Hasanaj has nothing to disclose.
John-Ross Rizzo	No disclosure on file
Eyal Muscal	Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer.
Bum Chun Suh	No disclosure on file
Atul T. Patel	Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
Yael Cohen	Yael Cohen has nothing to disclose.
Sheila Oren, MD, MBA	Sheila Oren, MD, MBA has received personal compensation for serving as an employee of Neuroderm. Sheila Oren, MD, MBA has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuroderm.
Xiaoyang Lan, PhD	No disclosure on file
Elisabetta Mascia	Elisabetta Mascia has nothing to disclose.
Brandon Francis, MD	Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovian. Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Montgomery and Associates.
Mesude Tutuncu	Dr. Tutuncu has nothing to disclose.
Veronica A. Tkachuk	Veronica A. Tkachuk has nothing to disclose.
Lil-Antonia Meyer-Arndt, MD, PhD	No disclosure on file
Tatjana Pekmezovic	No disclosure on file
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Chaitanya Amrutkar, MD	No disclosure on file
Amina Nasri, MD	Dr. Nasri has nothing to disclose.
Saul Reyes, MD	Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Hussein Yassine, MD	Hussein Yassine, MD has nothing to disclose.
Adam Brickman, PhD	Adam Brickman, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IQVIA. Adam Brickman, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cognito Therapeutics. Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Illinois. Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NovoNordisk. Adam Brickman, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. Adam Brickman, PhD has stock in Tau Biosciences. Adam Brickman, PhD has stock in CogniScreen.
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Daniel R. Gold, DO	Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care.
Preethish Kumar Veeramani, MBBS, PhD, FRCP(Lon)	Dr. Veeramani has nothing to disclose.
Nirali Vora, MD	Dr. Vora has nothing to disclose.
Kristen K. Steenerson, MD, FAAN	Dr. Steenerson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otolith. The institution of Dr. Steenerson has received research support from Wu Tsai Neurosciences Institute, Stanford University.
Robert T. Watson, MD, FAAN	No disclosure on file
Paul M. Katz, MD	Dr. Katz has nothing to disclose.
Louisa Kalsner, MD	No disclosure on file
Mohamed Falah, MD, FAAN	Dr. Falah has nothing to disclose.
Nicholas S. Potter, MD, PhD	Dr. Potter has nothing to disclose.
Minerva Lopez Ruiz, MD	Dr. Lopez Ruiz has nothing to disclose.
Vanessa Baute Penry, MD	Dr. Baute Penry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alfasigma.
Daniel B. Snyder, PhD	No disclosure on file
Derek Yuan, MD, FAAN	Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Michelle Fullard, MD	Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.
Ali K. Al Balushi, MD	No disclosure on file
Eslam H. Shosha, MD	Dr. Shosha has nothing to disclose.
Osigwe P. Agabi, MD	No disclosure on file
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Nasser Alzahrani, MD	No disclosure on file
Erik Z. Krause, DO	No disclosure on file
Sarah Gheuens, MD	No disclosure on file
S.S. Surenthiran, MBBS	No disclosure on file
Olubunmi Omojowolo, MD	No disclosure on file
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Marisa P. McGinley, DO	Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Charenya Anandan, MD	Dr. Anandan has nothing to disclose.
Arpita Lakhotia, MD, FAAN	Dr. Lakhotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Anja Thormann, MD, PhD	No disclosure on file
Evan R. Schloss, MD	Dr. Schloss has nothing to disclose.
Juliana J. Coleman, MD	No disclosure on file
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Tarun Girotra, MD	Dr. Girotra has nothing to disclose.
Manmeet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Abhishek Lunagariya, MD	No disclosure on file
Yu Zhao, MD	No disclosure on file
Venkatraman Karthikeayan, MD	No disclosure on file
Elina Zakin, MD, FAAN	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Ruihao Wang, MD	Dr. Wang has nothing to disclose.
Alison L. Christy, MD, PhD, FAAN	Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
Urvish K. Patel	Mr. Patel has nothing to disclose.
Chiara Zecca, MD	Prof. Zecca has nothing to disclose.
Uwe Zettl	Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Zettl has received research support from BMBF(Government).
Yi Li, MD	The institution of Dr. Li has received research support from AES. The institution of Dr. Li has received research support from NIH.
Alexander Levit	No disclosure on file
Ana Cristina W. Dos Santos	No disclosure on file
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Monica M. Chavarria, MD	No disclosure on file
Daniel Glaze, MD	Dr. Glaze has nothing to disclose.
Stuart Peltz	No disclosure on file
Ester Carreon Guarnizo	Ester Carreon Guarnizo has nothing to disclose.
Jennie Medin	No disclosure on file
Sirin Gandhi, MBBS	Dr. Gandhi has nothing to disclose.
Balasubramanian Samivel, MD	Dr. Samivel has nothing to disclose.
Muniza Sheikh	Ms. Sheikh has received personal compensation for serving as an employee of The Emmes Company.
Joy R. Esterlitz	No disclosure on file
Ihtesham Qureshi, MD	No disclosure on file
Philippe Picaut	No disclosure on file
John Maeglin	Mr. Maeglin has nothing to disclose.
Carol Swetlik, MD	An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Robert C. Stowe, MD	Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kherkher Garcia, LLP.
Allison Snyder, MD	Dr. Snyder has nothing to disclose.
Sonam C. Bhalla, MD	Dr. Bhalla has nothing to disclose.
Sunhee Kim, MD	No disclosure on file
Mohannad Assiri	Mohannad Assiri has nothing to disclose.
Michael Bazelot, PhD	No disclosure on file
Ninad Desai, MBBS	Dr. Desai has nothing to disclose.
Noelia García Lax	No disclosure on file
Todd Hudson	No disclosure on file
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Mahesh Jayaraman	No disclosure on file
Marti Juanola-Falgarona, PhD	No disclosure on file
Kishin Koh, MD, PhD	No disclosure on file
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
José Ángel Motos García	No disclosure on file
Saba Rammal, MD	No disclosure on file
Jenelle Raynowska, MD	Dr. Raynowska has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Intellisphere, LLC .
Stefan Sillau	Stefan Sillau has nothing to disclose.
Victoria Smith	No disclosure on file
Hongki Song	No disclosure on file
Michelle L. Sudyn	No disclosure on file
Prateek Thatikunta, MD	No disclosure on file
Shawn Whitehead	No disclosure on file
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Diana M. Barratt, MD, MPH, FAAN	Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Vlantis Law, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Traub Lieberman. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Callahan Fusco. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Chane Socarras. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conroy Simberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Crandall & Katt. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelley Kronenberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Plakas Mannos. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marshall Denehey. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pritt & Spano. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Russo Law.
Franchesca Fiorito Torres, MD	Dr. Fiorito Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Fiorito Torres has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli-Lilly. Dr. Fiorito Torres has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biohaven. Dr. Fiorito Torres has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Fiorito Torres has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis.
Anne-Katrin Giese, MD	Dr. Giese has nothing to disclose.
Jose-Alberto Palma, MD, PhD, FAAN	Dr. Palma has received personal compensation for serving as an employee of Eli Lilly. The institution of Dr. Palma has received research support from National Institutes of Health. Dr. Palma has received publishing royalties from a publication relating to health care.
Luciano A. Sposato, MD	Dr. Sposato has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gore.
Mauricio R. Delgado, MD, FRCPC, FAAN	Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv. The institution of Dr. Delgado has received research support from Ipsen.
Bernard Rosenblatt, MD, FAAN	No disclosure on file
Sheryl L. Strasser, MD	Dr. Strasser has nothing to disclose.
Gretchen K. Von Allmen, MD	No disclosure on file
Mary Catherine George, PhD	Ms. George has or had stock in Gnomx. The institution of Ms. George has received research support from Icahn School of Medicine at Mount Sinai. Ms. George has received intellectual property interests from a discovery or technology relating to health care.
Dhanashri P. Miskin, MD	Dr. Miskin has nothing to disclose.
Athina Papadopoulou, MD	The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Schweiz AG. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie AG. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Papadopoulou has received research support from Freie Akademische Gesellschaft Basel . Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving as a Travel Support (for Congress) with Eli Lilly. Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving as a Travel support (for Congress) with TEVA.
Suma Babu, MD, MPH	The institution of Dr. Babu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Dr. Babu has received personal compensation in the range of $0-$499 for serving as a Consultant for Specific Biologics. The institution of Dr. Babu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure Therapeutics. The institution of Dr. Babu has received research support from Biogen. The institution of Dr. Babu has received research support from Ionis. The institution of Dr. Babu has received research support from OrphAI therapeutics. The institution of Dr. Babu has received research support from Denali Therapeutics. The institution of Dr. Babu has received research support from Tiziana. Dr. Babu has a non-compensated relationship as a Appointed Member of the Committee on ALS: Accelerating Treatments and Improving Quality of Life with National Academies of Sciences, Engineering and Medicine that is relevant to AAN interests or activities.
Aaron F. Struck, MD	The institution of Dr. Struck has received research support from Ceribell.
Michael DiSano, MD	No disclosure on file
Gamaleldin M. Osman, MD	Dr. Osman has nothing to disclose.
Abdulaziz S. Al Sultan, MD	Dr. Al Sultan has nothing to disclose.
Leanne Stunkel, MD	Dr. Stunkel has nothing to disclose.
Antonio Moya, MD, FAAN	Dr. Moya has nothing to disclose.
Anai C. Hamasaki, MD	No disclosure on file
Cheryl Smith, MD	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Smith has received research support from Sanofi. The institution of Dr. Smith has received research support from Alexion. The institution of Dr. Smith has received research support from Susan Dorsch Research Fund.
Colin Wilbur, MD	No disclosure on file
Zahra N. Rezvani, MD	No disclosure on file
Justin Kao, MBChB	No disclosure on file
John Parker, MD	No disclosure on file
Nicole Rosendale, MD, FAAN	Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Rosendale has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Rosendale has received research support from American Academy of Neurology. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. The institution of Dr. Rosendale has received research support from The Dana Foundation. The institution of Dr. Rosendale has received research support from UArizona-Banner All of Us Seed Grant. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Laura S. Surillo Dahdah, MD	No disclosure on file
Bhavana Sharma, MD	No disclosure on file
Alireza Bozorgi, MD	No disclosure on file
Julia N. Bucklan, DO	Dr. Bucklan has nothing to disclose.
Tapan Mehta, MD	Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Balt, Medtronic, J&J, Terumo.
Siew Mei Yap, MBBS	Dr. Yap has received research support from Novartis.
Hessa Alotaibi, MD	No disclosure on file
Greg D. Kuhlman, MD	Dr. Kuhlman has nothing to disclose.
David F. Cuellar Giraldo, Jr., MD	Dr. Cuellar Giraldo has nothing to disclose.
Reed Johnson	No disclosure on file
Elison H. Sarapura Castro, MD	No disclosure on file
Abdul Rahman Alchaki, MD	Dr. Alchaki has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Sherita Alai	No disclosure on file
Lars Bergmann, MD	Dr. Bergmann has received personal compensation for serving as an employee of Abbvie. Dr. Bergmann has or had stock in Abbvie.
Khalil Husari, MD	The institution of Dr. Husari has received research support from Maryland Innovation Initiative.
Penny D. McQueen	No disclosure on file
Lucas Meira Benchaya, MD	Dr. Meira Benchaya has nothing to disclose.
Nitish Chourasia, MD	Dr. Chourasia has nothing to disclose.
Shivakrishna Kovi, MD, MBBS	Dr. Kovi has nothing to disclose.
Yoshimi Hisamoto, MD	Dr. Hisamoto has nothing to disclose.
Sandeep Devarapalli, MD	No disclosure on file
Sleiman El Jamal, MD	Dr. El Jamal has nothing to disclose.
Subin Mathew, MD, FAAN	Dr. Mathew has nothing to disclose.
Reema Choudhry, MD	Dr. Butt has nothing to disclose.
Evgenia Alexandrova, MD	No disclosure on file
Shivkumar Bhadola, MD	Dr. Bhadola has stock in IONIS PHARMACEUTICALS INC. Dr. Bhadola has stock in GINKGO BIOWORKS HOLDINGS INC.
Heather Newman	No disclosure on file
Joshua Chodosh, MD	The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NINR.
Tamar Rachmilewitz	No disclosure on file
Naomi Mezaki	No disclosure on file
Ferdinand Schweser, PhD	Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Robin S. Feldman	No disclosure on file
Lawrence Hewitt	Lawrence Hewitt has received personal compensation for serving as an employee of Lundbeck.
Viet-Huong Nguyen, PharmD, MPH, MS	Dr. Nguyen has nothing to disclose.
Benjamin Sanchez, PhD	No disclosure on file
Takeshi Miura	No disclosure on file
Mohammed Alqahtani	Mohammed Alqahtani has nothing to disclose.
Karina Milla-Neyra	No disclosure on file
Roman Rubio	Roman Rubio has received personal compensation for serving as an employee of Revance.
Leonardo V. Modenezi, MD	No disclosure on file
Subhendu Rath, MBBS	Dr. Rath has nothing to disclose.
Jose Meca Lallana, MD	Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Bhavani Kashyap, MBBS, PhD	Dr. Kashyap has nothing to disclose.
Kelly J. Meza Capcha, Sr.	No disclosure on file
Rohit Gummi, MD	Dr. Gummi has nothing to disclose.
Rabia Jamy, MD	Dr. Jamy has nothing to disclose.
Harshad Ladha, MD	Dr. Ladha has nothing to disclose.
Elizabeth Pedowitz, MD	No disclosure on file
Devin E. Prior, MD	No disclosure on file
Raffaella Umeton, MD, PhD, MMSc	Dr. Umeton has nothing to disclose.
Payam Moein, MD	No disclosure on file
Matthew Broderick, MD	Dr. Broderick has nothing to disclose.
Youssef Al Said, MBBS	No disclosure on file
Smit D. Patel, MD, MPH	Dr. Patel has nothing to disclose.
Lucy Cobbs	No disclosure on file
Kavneet Kaur, MD	Dr. Kaur has nothing to disclose.
Shervin Badihian, MD	Dr. Badihian has nothing to disclose.
Maryenela Z. Illanes-Manrique, MD, Atlantic Fellow	The institution of Dr. Illanes-Manrique has received research support from GLOBAL BRAIN HEALTH INSTITUTE.
Erick Figueroa-Ildefonso	No disclosure on file
Maria G. Martucci, MD	Dr. Martucci has nothing to disclose.
Ivie Tokunboh	No disclosure on file
Katrina T. Schrader, MA, CCRP	No disclosure on file
Marcello Ziosi, PhD	No disclosure on file
Jamie Wong, PhD	Dr. Wong has nothing to disclose.
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Suyog U. Pol, PhD	Dr. Pol has nothing to disclose.
Sandeep Sharma, MD, DrPH	Dr. Sharma has nothing to disclose.
Clara Guaschino	No disclosure on file
Mohamad J. Alshikho, MD	No disclosure on file
Simona Nedelcu, MD, PhD	No disclosure on file
Masaki Tanaka	No disclosure on file
Sam Olum, MD	No disclosure on file
Chenchen Tan, MD	No disclosure on file
Pierpaolo Turcano, MD	Dr. Turcano has nothing to disclose.
Gyujoon Hwang	No disclosure on file
Kseniia K. Kriukova	No disclosure on file
Jose Maria Cabrera Maqueda	Mr. Cabrera Maqueda has nothing to disclose.
Ihtesham A. Qureshi, MD	No disclosure on file
Suzanne Liu, MD	The institution of an immediate family member of Dr. Liu has received research support from NIH.
Laura J Weinkle, MS	No disclosure on file
Larissa Felt	No disclosure on file
Kristen R. Joseph, MA	No disclosure on file
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Raima A. Memon, MBBS	Dr. Memon has nothing to disclose.
Sarah Tanveer, PhD, MA	The institution of Miss Tanveer has received research support from Laura and Arnold Foundation. The institution of Miss Tanveer has received research support from Food and Drug Administration.
Gopal K. Dash, DM	Dr. Dash has nothing to disclose.
Tina M. Burton, MD	Dr. Burton has nothing to disclose.
Burcu Zeydan, MD	The institution of Dr. Zeydan has received research support from National Institutes of Health.
Tara R. Rastin, MD	No disclosure on file
Stephanie L. Bissonnette, DO	The institution of Dr. Bissonnette has received research support from SAGE Therapeutics. The institution of Dr. Bissonnette has received research support from Huntington's Disease Society of America. The institution of Dr. Bissonnette has received research support from CHDI Foundation.
Mingyang Meah Gao, MD	No disclosure on file
Michael Hansen, MD	No disclosure on file
Sindhu V. Richards, MD	No disclosure on file
Tayyba Anwar, MD	No disclosure on file
Juma Mbwana, MD	No disclosure on file
Serena J. Shimshak, BA	No disclosure on file
Zuolu Liu, MD	No disclosure on file
Michael Porambo	Mr. Porambo has nothing to disclose.
Emily Elliott, DO	Dr. Elliott has nothing to disclose.
Patama Gomutbutra, MD	No disclosure on file
Alessandro d'Ambrosio	Alessandro d'Ambrosio has nothing to disclose.
Marcus Cimino, MD	No disclosure on file
Sylvia Soo, MD	No disclosure on file
Isin Unal-Cevik, MD, PhD	The institution of Prof. Unal-Cevik has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Viatris .
Ilaria Cani, MD	No disclosure on file
Mohammad Alkhoujah, MD	Dr. Alkhoujah has nothing to disclose.
Oday Halhouli, MD	Dr. Halhouli has nothing to disclose.
Laura S. Munoz-Arcos, MD	No disclosure on file
Maria M. Galardi, MD	Dr. Galardi has nothing to disclose.
Jordan J. Cole, MD	The institution of Dr. Cole has received research support from Child Neurology Career Development Program K12 (through NINDS, 5K12NS098482-07). Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with American Epilepsy Society.
Leah Loewenstein, PharmD	No disclosure on file
Abid Kareem	No disclosure on file
Mamdouh H. Kalakatawi, MD, FAAN	No disclosure on file
Ghadah H. Altowaijri, MD	No disclosure on file
Mousa A. Almejally, MD	No disclosure on file
Hussein Al Gahtani	No disclosure on file
Ali A. Al-Mubarak, MD	No disclosure on file
Sadaga H. Alawi, MD	No disclosure on file
Shireen Al-Qureshi, MD, FRCPC, FAAN	No disclosure on file
Abdulrahman O. Almalki, MD	No disclosure on file
Patrick Drummond, MD	Dr. Drummond has nothing to disclose.
Swathy Chandrashekhar, MD	Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
Hyun-Wook Nah, MD	Dr. Nah has nothing to disclose.
David A. Discua	No disclosure on file
Iris Martinez	Iris Martinez has nothing to disclose.
Nazila Rad, MD	No disclosure on file
Chelsea S. Chen	Ms. Chen has nothing to disclose.
Ifat Vigiser	Ifat Vigiser has nothing to disclose.
Joela T. Mathews, MRPSGB	Miss Mathews has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Miss Mathews has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Miss Mathews has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celegene.
Lydia J. Bernhardt	No disclosure on file
Laetitia Pouzol	Laetitia Pouzol has received personal compensation for serving as an employee of Idorsia. Laetitia Pouzol has stock in Idorsia.
Marcio N. Souza, MD	Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lilly. Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA. Dr. Souza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Libbs. Dr. Souza has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie.
Magnus Spangsberg Boesen, MD	Dr. Spangsberg Boesen has nothing to disclose.
Morten B. Blinkenberg, MD, PhD	The institution of Morten Bjorn Blinkenberg, MD, PhD has received research support from Danish MS Society.
Mohamed Taha, MD	Dr. Taha has nothing to disclose.
Mohamed K. Abdelbary II, MBBS	Dr. Abdelbary has nothing to disclose.
Nabeel M. Syed, MBBS	No disclosure on file
Farheen Niazi, MBBS, FCPS Neurology, FEBN, MRCP UK	No disclosure on file
Muhammad A. Javed, MD	No disclosure on file
Jessy Walia, MBBS	No disclosure on file
M O. Abdulghani, MD	No disclosure on file
Magd F. Zakaria, MD	Dr. Zakaria has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Bayer, Novartis, Sanofi Genzyme, Roche and Biogen.
Hany M. Aref, MD, FAAN	Dr. Aref has nothing to disclose.
Lakshmi Arbatti, NLP	Mrs. Arbatti has received personal compensation for serving as an employee of Grey Matter Technologies, LLC.
Carol Christopher	No disclosure on file
Muhammad O. Salim Khan, DO	Dr. Salim Khan has nothing to disclose.
Katherine Labiner, MD	Dr. Labiner has nothing to disclose.
Marcelo Lobo, MD	No disclosure on file
Michael Doyle, MRCPI	No disclosure on file
John M. Lynch, MD	No disclosure on file
Mithila Fadia, MBBS	No disclosure on file
Robert S. Eisinger, MD, PhD	The institution of Dr. Eisinger has received research support from NIH.
Spurthi Surpur, MD	Dr. Surpur has nothing to disclose.
David K. Chan, MD	Dr. Chan has nothing to disclose.
Dolores Torres, MD	Dr. Torres has nothing to disclose.
Kirsten Martin	No disclosure on file
Yi Tong	No disclosure on file
Ajal Dave, MD	No disclosure on file
Panagiotis Zis, MBBS, PhD	No disclosure on file
Gina L. Hadley, MD	Dr. Hadley has nothing to disclose.
Ashmanie Mahatoo, MD	No disclosure on file
Michael B. Nelson, MD, MPH	No disclosure on file
Janaki Patel, MD	Dr. Patel has nothing to disclose.
Jeremiah F. Bell, MD	No disclosure on file
Ranbir Ahluwalia	No disclosure on file
Evan Fitzgerald	No disclosure on file
Brooke Hartenstein	Ms. Hartenstein has nothing to disclose.
Eugene Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of ionis pharmaceuticals.
Asad Ikram, MD, MBBS	Dr. Ikram has nothing to disclose.
Piotr Bzdyra, MD	No disclosure on file
Joao Marcos C. Ferreira, Sr., MD	No disclosure on file
Barbara F. Diniz, MD	No disclosure on file
Yuri S. Macedo, MD	No disclosure on file
Guilherme S. Torezani, MD	Dr. Torezani has nothing to disclose.
Pedro H. Macedo, Sr., MD	No disclosure on file
Ernesto N. Alonso-Labori, MD	No disclosure on file
Christopher Calder, MD, PhD, FAAN	No disclosure on file
Johan Van Hove	The institution of Johan Van Hove has received research support from CureARS, NIH, NKH Crusaders, Mito Foundation, Brodyn's Friends, Les Petits Bourdons, Maud & Vic NKH fund, Tucker's Titans, Mikaere foundation. Johan Van Hove has received intellectual property interests from a discovery or technology relating to health care.
James Ellis	No disclosure on file
William Zeiger, MD, PhD	No disclosure on file
Fredric J. Cohen, MD	No disclosure on file
Raisa Saron W. Murari, MD	No disclosure on file
Fabio F. Martins, MD	No disclosure on file
Priyanka Madaan	Priyanka Madaan has nothing to disclose.
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Muhammad Rizwan Husain, MD	Dr. Husain has nothing to disclose.
Vladana Markovic	No disclosure on file
Miguel A. Pappolla, MD	No disclosure on file
William G. Mantyh, MD	No disclosure on file
Behnaz Esmaeili, MD	No disclosure on file
Omar Akhand, MD	Dr. Akhand has nothing to disclose.
Christopher Kenney	No disclosure on file
Soren Jonzzon	No disclosure on file
Leena Suleiman, MD	No disclosure on file
Panayiota Trifillis	Panayiota Trifillis has received personal compensation for serving as an employee of PTC Therapeutics. Panayiota Trifillis has received stock or an ownership interest from PTC Therapeutics, Inc.. Panayiota Trifillis has received intellectual property interests from a discovery or technology relating to health care.
Diana X. Bharucha-Goebel, MD	No disclosure on file
Katelyn E. Gay	Ms. Gay has received personal compensation for serving as an employee of The Emmes Company, LLC.
Sitara Koneru, MD	Dr. Koneru has nothing to disclose.
Wael O. Amer, MD	No disclosure on file
Helene Parpal, MD	No disclosure on file
Claudio Santos	No disclosure on file
Chad Oh	Chad Oh has nothing to disclose.
Kushal Naik	No disclosure on file
Kimberly Geronimo	No disclosure on file
Jazmin G. Sotelo-Hernandez, MD	No disclosure on file
Salvador Vazquez	No disclosure on file
Alejandra Duque Ramirez, MD	Dr. Duque Ramirez has nothing to disclose.
Jorge Patiño	No disclosure on file
William H. Duong	No disclosure on file
Brian Toh	Brian Toh has nothing to disclose.
Christina M. Lewis	No disclosure on file
Walter Maier-Janson, MD	Dr. Maier-Janson has nothing to disclose.
Fang Zhang	No disclosure on file
Disha Kohli, MD, MBBS	Dr. Kohli has nothing to disclose.
Sascha Gill, MSc	No disclosure on file
Miad F. Albalawi, Jr., MD	No disclosure on file
Ashwaq Alshahrani, MD	No disclosure on file
Faleha Zafar, MBBS	No disclosure on file
Asri Yuliati, MD	No disclosure on file
Yasmin Aghajan, MD	Dr. Aghajan has nothing to disclose.
Sean Evans, MD	No disclosure on file
Evan Rosenberg, MD, PhD	No disclosure on file
Olivia Gardner, MD, PhD	No disclosure on file
Shehryar Sheikh	No disclosure on file
Peony Pak, MD	Dr. Pak has nothing to disclose.
Mayra Montalvo Perero, MD	Dr. Montalvo Perero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG THERAPEUTICS. Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN.
Pratheep Kumar S, MD	No disclosure on file
Tarini Goyal	Dr. Goyal has nothing to disclose.
Khurram Janjua, MD	No disclosure on file
Eric Huttler	No disclosure on file
Minyoul Baik, Jr., MD	Dr. Baik has nothing to disclose.
Ria Pal, MD	Dr. Pal has nothing to disclose.
Takeshi Iwatsubo	No disclosure on file
Fang Bai, MD	No disclosure on file
Tekalign Burka, MD	Dr. Burka has nothing to disclose.
Kenneth Jackson, PharmD	No disclosure on file
Michelle Widolff Cyr, PhD	No disclosure on file
Elias Samaha, MD	Dr. Samaha has nothing to disclose.
Natalia Gonzalez, MD	No disclosure on file
Helena Gossye	Mrs. Gossye has nothing to disclose.
Seena Vengalil, MD	Dr. Vengalil has nothing to disclose.
Briseida E. Feliciano Astacio, MD, FAAN	Dr. Feliciano Astacio has received research support from NIA/NIH. Dr. Feliciano Astacio has received intellectual property interests from a discovery or technology relating to health care.
Larry Adams	No disclosure on file
Heriberto A. Acosta, MD	Dr. Acosta has nothing to disclose.
Michael L. Cuccaro	No disclosure on file
Maryam Shakir, MPH	No disclosure on file
Karan K. Topiwala, MBBS	No disclosure on file
Stefan Dukic	No disclosure on file
Benjamin Farley	No disclosure on file
Shreya Agarwal	No disclosure on file
Siddharth Gupta, MD	No disclosure on file
Daniel M. Oh, MD	Dr. Oh has nothing to disclose.
Erin O'Rourke	No disclosure on file
Janani Kassiri, MD, PhD	Dr. Kassiri has nothing to disclose.
Thilinie N. Rajapakse, MD	Dr. Rajapakse has nothing to disclose.
Victor Lira, MD	No disclosure on file
Rebekah G. Langston	Ms. Langston has nothing to disclose.
Phioanh L. Nghiemphu, MD, FAAN	Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simpson Healthcare. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springswork. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Nghiemphu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Springworks. The institution of Dr. Nghiemphu has received research support from Erasca. The institution of Dr. Nghiemphu has received research support from Springswork. The institution of Dr. Nghiemphu has received research support from Children's Tumor Foundation. The institution of Dr. Nghiemphu has received research support from NIH-NCI . The institution of Dr. Nghiemphu has received research support from DOD. The institution of Dr. Nghiemphu has received research support from GCAR.
JIGNESH parajapati	No disclosure on file
Marcus Vinicius R. Pinto, MD	Dr. Pinto has nothing to disclose.
Pablo A. Lopez, MD	No disclosure on file
Ryan G. Taylor, MD	Dr. Taylor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REACH Market Research.
Anna Olsson	No disclosure on file
Peter Oturai, MD	No disclosure on file
Shymaa Hussain, MBBS	No disclosure on file
Adil Harroud, MD	Dr. Harroud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Harroud has received research support from National Multiple Sclerosis Society. The institution of Dr. Harroud has received research support from Multiple Sclerosis Society of Canada.
Enrique Urrea-Mendoza, MD	Dr. Urrea-Mendoza has nothing to disclose.
Rajiv Patni, MD	No disclosure on file
Pedro Renato D. Brandao, MD	No disclosure on file
Farris Taha, MD	Dr. Taha has nothing to disclose.
Joan B. Cracco, MD	No disclosure on file
Radha Giridharan, MD, MBBS	No disclosure on file
David Ashton, MD	No disclosure on file
Horia A. Ijacu, MD	No disclosure on file
Pavnit Kukreja, PharmD	Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
Beverly Reynolds	Beverly Reynolds has nothing to disclose.
Talyta Grippe, MD	Dr. Grippe has nothing to disclose.
Natalia S. Cunha, MD	Dr. Cunha has nothing to disclose.
Arooshi Kumar, MD	Dr. Kumar has nothing to disclose.
Fanny Herisson, MD	No disclosure on file
Mary O. Hollist, DO	No disclosure on file
Stacie L. Demel, DO	Dr. Demel has nothing to disclose.
Kishan Ughreja, BA	No disclosure on file
Hsiao-Yuan Lee	No disclosure on file
Harish Jayakumar, MD MRCP DM DNB FRCP FEBN PDF, FAAN	No disclosure on file
Emma Benn	No disclosure on file
Eoin Finegan, MBBS	Dr. Finegan has nothing to disclose.
Ibrahim Laleka	No disclosure on file
Tobias Sejbaek, MD, PhD	Prof. Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, NeuroXpharm, Novartis, Roche, Sandoz and Sanofi. The institution of Prof. Sejbaek has received research support from Merck, Novartis, Roche and Sanofi.
Jens Leander	No disclosure on file
Malcolm L. McDonald	No disclosure on file
Usman Shehzad, MD	No disclosure on file
Alexander C. Ou, MD	Dr. Ou has nothing to disclose.
Tiffany Sheehan	No disclosure on file
Mathieu Cuchanski, DO	Dr. Cuchanski has nothing to disclose.
Olwen Murphy, MD	Dr. Murphy has nothing to disclose.
Martha L. Cruz, MD	No disclosure on file
Angelika Bauer, PhD	No disclosure on file
Gisbert Weckbecker	No disclosure on file
John Svaren, PhD	No disclosure on file
Pumanshi Talwar	No disclosure on file
Souhel Najjar, MD	Dr. Najjar has nothing to disclose.
Bhavna Kaul, MD	No disclosure on file
Surekha Dabla, MD	Dr. Dabla has nothing to disclose.
Kuljeet S. Anand, MD	No disclosure on file
Rajanigandhi Hanumanthu, MD	No disclosure on file
Dhara Murray-Frank, MD	Dr. Murray-Frank has nothing to disclose.
Michal Obrzut	Michal Obrzut has nothing to disclose.
Elizabeth A. Coffee, MD	The institution of Dr. Coffee has received research support from NIH.
Shemonti Hasan, MD	Dr. Hasan has nothing to disclose.
Medha Gudavalli	No disclosure on file
Andrew Lockhart, MB, BAO, BCh, MSc	The institution of Dr. Lockhart has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. Lockhart has received research support from European Charcot Foundation.
Rebecca Luke, DO	Dr. Luke has nothing to disclose.
Muhammad Adeel Saleemi, MBBS	The institution of Dr. Saleemi has received research support from NIH.
Rahul H. Rahangdale, MD	Dr. Rahangdale has nothing to disclose.
Eric Schmidt, PhD	No disclosure on file
Lucy Honeycutt	No disclosure on file
Leila Sellami, MD	Dr. Sellami has nothing to disclose.
Nonita Mittal, MBBS	No disclosure on file
Zhen Xiao, PhD	No disclosure on file
Shammy Chandel	No disclosure on file
Christopher Domen	Christopher Domen has nothing to disclose.
Farren Briggs, PhD	The institution of Prof. Briggs has received research support from NIH.
Marie Wencel, CCRP	Ms. Wencel has nothing to disclose.
Ely G. Cuberos Paredes	Ms. Cuberos Paredes has nothing to disclose.
Osemwegie Nosakhare, MBBS	No disclosure on file
Yoon-Jae Cho, MD	No disclosure on file
Sophia Woodson	No disclosure on file
Nancy Sacco	No disclosure on file
Chintan K. Rupareliya, MD	Dr. Rupareliya has nothing to disclose.
Christian Kim	No disclosure on file
Ornella A. Oluwole	No disclosure on file
Cassio Henrique Taqu Martins	No disclosure on file
Maria Castaneda	No disclosure on file
Jake McKay, MD	Dr. McKay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Caitlin D'Souza, DO	No disclosure on file
Christopher Smelick, MD	No disclosure on file
Pria Anand, MD	Dr. Anand has nothing to disclose.
Lakshmi Pillai	Ms. Pillai has nothing to disclose.
Jacob Didion, MD	No disclosure on file
Adam J. Margolius, MD	Dr. Margolius has nothing to disclose.
Kevin A. Yeboah, MD	No disclosure on file
Nicole Heinl	No disclosure on file
Adam Bartsch	No disclosure on file
Carol Taylor-Burds	No disclosure on file
Justin Voorhees, MD	No disclosure on file
Saloua Mrabet, MD	Dr. Mrabet has nothing to disclose.
Amina Gargouri Ep Berrechid	No disclosure on file
Yash Chaudhry, DO	No disclosure on file
Richard H. Haas, MD	Dr. Haas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SPARC. Dr. Haas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Haas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Law Firms. Dr. Haas has stock in Various Companies Stock Trading. The institution of Dr. Haas has received research support from NIH North American Mitochondrial Disease Consortium. The institution of Dr. Haas has received research support from Reneo Pharma. The institution of Dr. Haas has received research support from Astellas Pharma. The institution of Dr. Haas has received research support from Acadia Pharma. The institution of Dr. Haas has received research support from Taysha Gene Therapies. The institution of Dr. Haas has received research support from Tisento Pharma.
Dongin Sinn, MD	The institution of Dr. Sinn has received research support from Theravance BioPharma. The institution of Dr. Sinn has received research support from Dysautonomia International.
Irina Krugomova, PA	No disclosure on file
Lydia Marcus, MD	Dr. Marcus has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ragsdale LLC. The institution of Dr. Marcus has received research support from NIAID.
Iffat Ara Suchita, MD	Dr. Suchita has nothing to disclose.
Victoria A. Cannon, MD	No disclosure on file
Benjamin Chipper Doudican	Mr. Doudican has nothing to disclose.
Stephanie Manberg, DO	The institution of Dr. Manberg has received research support from AMO.
Dace Almane	No disclosure on file
Eun-Kee Bae	No disclosure on file
Reyna M. Duron, MD	No disclosure on file
Anna Geraghty	No disclosure on file
Shubham Misra, PhD	Dr. Misra has nothing to disclose.
Shivani Naik, MD	Dr. Naik has nothing to disclose.
Marufjon Salokhiddinov, MD	No disclosure on file
Danielle Larson, MD	Dr. Larson has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia Pharmaceuticals.
Monique M. Montenegro, MD	Dr. Montenegro has nothing to disclose.
Aman Dabir, MD, FAAN	Dr. Dabir has nothing to disclose.
Guillermo R. Delgado-Garcia, MD, MSc	Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Team Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Brain and Life en Espanol that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Neurology Clinical Practice that is relevant to AAN interests or activities.
Katherine Werbaneth, MD	Dr. Werbaneth has nothing to disclose.
Elisabeth Golden, MD	Dr. Golden has nothing to disclose.
Jin Myoung Seok, MD	Jin Myoung Seok has nothing to disclose.
Neel Patel, MBBS	No disclosure on file
Matthew Koster	The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rigel. The institution of Matthew Koster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Matthew Koster has received research support from Sobi.
Elizabeth Davis	No disclosure on file
Nathan Kung	No disclosure on file
Benjamin Wissel	No disclosure on file